U.S.UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

  

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 20192020

or

 

TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT

 

For the Transition Period from              to

 

Commission file number 1-13463

 

BIO-KEY INTERNATIONAL, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

DELAWARE

41-1741861

(State or Other Jurisdiction of Incorporation of Organization)

(IRS Employer Identification Number)

 

3349 HIGHWAY 138, BUILDING A, SUITE E, WALL, NJ  07719

(Address of Principal Executive Offices) (Zip Code)

 

(732) 359-1100

(Registrant’s telephone number, including area code)

 

Securities registered pursuance to Section 12(b) of the Act:

 

Title of each class

Trading Symbol

Name of each exchange on which

registered

 

 

 

Common Stock, par value $0.0001 per share

BKYI

Nasdaq Stock marketCapital Market

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ☒   No  ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒   No  ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Accelerated filer ☐

Smaller Reporting Company ☒

Non-accelerated filer 

Emerging growth company  ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

  

Indicate by check mark whether the registrant is a shell company (as defined by rule 12b-2 of the Exchange Act)  Yes  ☐  No  ☒

 

Number of shares of common stock, $.0001 par value per share, outstanding as of November 12, 201913, 2020 was 14,408,546.62,412,558.  

 


 

 

BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES

  

INDEX

 

PART I. FINANCIAL INFORMATION  

 

 

 

Item 1

Condensed Consolidated Financial Statements (unaudited):

 

 

Balance sheets as of September 30, 20192020 (unaudited) and December 31, 20182019 (audited)

3

 

Statements of operations for the three and nine months ended September 30, 20192020 and 20182019

4

 

Statements of Stockholders’ Equity (deficit) for the three and nine months ended September 30, 20192020 and 20182019

5

 

Statements of cash flows for the nine months ended September 30, 20192020 and 20182019

7

 

Notes to condensed consolidated financial statements

9

Item 2

Management’s Discussion and Analysis of Financial Conditions and Results of Operations

22

25

Item 4

Controls and Procedures

2935

 

 

 

PART II. OTHER INFORMATION  

 

 

 

Item 2Unregistered Sales of Equity Securities and Use of Proceeds35

Item 6

Exhibits

2935

 

 

 

Signatures

3137

 


2

 

PART I -- FINANCIAL INFORMATION

 

BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

September 30,

2019

  

December 31,

2018

  

September 30,

2020

  

December 31,

2019

 
 

(Unaudited)

      

(Unaudited)

     

ASSETS

                

Cash and cash equivalents

 $78,240  $323,943  $18,395,508  $79,013 

Accounts receivable, net

  773,334   1,574,032   492,380   126,000 

Due from factor

  50,702   56,682   63,262   110,941 

Note receivable

  295,000   - 

Inventory

  971,167   998,829   399,396   429,119 

Prepaid expenses and other

  204,019   108,397 
Investment in debt security   516,121   512,821 

Total current assets

  20,365,686   1,366,291 

Resalable software license rights

  1,125,000   1,125,000   68,758   73,802 

Prepaid expenses and other

  183,216   150,811 
Investment – non-marketable security  512,821   - 

Total current assets

  3,694,480   4,229,297 

Resalable software license rights, net of current portion

  5,906,466   6,790,610 

Equipment and leasehold improvements, net

  117,644   148,608   78,941   95,509 

Capitalized contract costs, net

  254,957   319,199   149,860   231,519 

Deposits and other assets

  8,712   8,712   8,712   8,712 

Operating lease right-of-use assets

  611,883   -   556,915   566,479 

Intangible assets, net

  187,701   195,906   1,617,171   154,386 

Goodwill

  1,154,526   - 

Total non-current assets

  7,087,363   7,463,035   3,634,883   1,130,407 

TOTAL ASSETS

 $10,781,843  $11,692,332  $24,000,569  $2,496,698 
                

LIABILITIES

                

Accounts payable

 $496,667  $481,269  $314,546  $844,557 

Loans payable – related parties

  -   188,737 

Accrued liabilities

  478,541   548,232   399,756   572,885 

Convertible notes payable, net of debt discount and debt issuance costs

  1,859,635   -   -   2,255,454 

Deferred revenue

  222,721   196,609 

Note payable – PistolStar Acquisition, net of debt discount

  235,000   - 

Deferred revenue - current

  773,013   359,212 

Operating lease liabilities, current portion

  178,130   -   229,853   170,560 

Total current liabilities

  3,235,694   1,226,110   1,952,168   4,391,405 

Deferred revenue - long term

  40,492   - 

Operating lease liabilities, net of current portion

  426,879   -   325,454   390,466 

Total non-current liabilities

  426,879   -   365,946   390,466 

TOTAL LIABILITIES

  3,662,573   1,226,110   2,318,114   4,781,871 
                

Commitments

        

COMMITMENTS

        
                

STOCKHOLDERS’ EQUITY

                
                

Common stock — authorized, 170,000,000 shares; issued and outstanding; 14,398,701 and 13,977,868 of $.0001 par value at September 30, 2019 and December 31, 2018, respectively

  1,440   1,398 

Common stock — authorized, 170,000,000 shares; issued and outstanding; 62,376,443 and 14,411,432 of $.0001 par value at September 30, 2020 and December 31, 2019, respectively

  6,237   1,441 

Additional paid-in capital

  87,310,964   85,599,140   119,748,463   87,436,402 

Accumulated deficit

  (80,193,134

)

  (75,134,316

)

  (98,072,245

)

  (89,723,016

)

TOTAL STOCKHOLDERS’ EQUITY

  7,119,270   10,466,222 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 $10,781,843  $11,692,332 

TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)

  21,682,455   (2,285,173

)

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 $24,000,569  $2,496,698 

 

The accompanying notes to the condensed consolidated financial statements are an integral part of these statements.

 


3

 

BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

Three months ended

September 30,

  

Nine months ended

September 30,

  

Three months ended

September 30,

  

Nine months ended

September 30,

 
 

2019

  

2018

  

2019

  

2018

  

2020

  

2019

  

2020

  

2019

 
                                

Revenues

                                

Services

 $237,372  $225,739  $710,975  $777,309  $491,535  $237,372  $928,561  $710,975 

License fees

  98,272   210,651   241,780   467,621   346,479   98,272   605,366   241,780 

Hardware

  117,070   303,360   779,965   1,084,416   105,311   117,070   239,025   779,965 

Total Revenues

  452,714   739,750   1,732,720   2,329,346   943,325   452,714   1,772,952   1,732,720 

Costs and other expenses

                                

Cost of services

  65,683   97,965   214,933   373,538   173,823   65,683   336,940   214,933 

Cost of license fees

  369,604   757,288   1,119,147   2,297,390   10,775   369,604   29,486   1,119,147 

Cost of hardware

  73,366   85,079   458,049   478,652   27,011   73,366   117,900   458,049 

Total costs and other expenses

  508,653   940,332   1,792,129   3,149,580   211,609   508,653   484,326   1,792,129 

Gross Profit (Loss)

  (55,939

)

  (200,582

)

  (59,409

)

  (820,234

)

  731,716   (55,939

)

  1,288,626   (59,409

)

                                

Operating Expenses

                                

Selling, general and administrative

  915,066   1,049,270   3,350,770   3,587,308   1,490,241   915,066   4,083,568   3,350,770 

Research, development and engineering

  300,131   391,507   975,466   1,081,294   331,213   300,132   986,675   975,466 

Total operating expenses

  1,215,197   1,440,777   4,326,236   4,668,602   1,821,454   1,215,198   5,070,243   4,326,236 

Operating loss

  (1,271,136

)

  (1,641,359

)

  (4,385,645

)

  (5,488,836

)

  (1,089,738

)

  (1,271,137

)

  (3,781,617

)

  (4,385,645

)

                                

Other income (expense)

                                

Interest income

  19   44   143   64   1,106   19   26,908   143 

Government grant – Paycheck Protection Program

  -   -   340,819   - 

Interest expense

  (558,449

)

  -   (673,316

)

  -   (2,204,920

)

  (558,449

)

  (4,323,577

)

  (673,316

)

Loss on extinguishment of debt

  -   -   (499,076

)

  - 

Total other income (expense), net

  (558,430

)

  44   (673,173

)

  64   (2,203,814

)

  (558,430

)

  (4,454,926

)

  (673,173

)

Net loss

  (1,829,567

)

  (1,641,315

)

  (5,058,818

)

  (5,488,772

)

  (3,293,552

)

  (1,829,567

)

  (8,236,543

)

  (5,058,818

)

Deemed dividend from trigger of anti-dilution provision feature

  -   (1,428,966

)

  -   (1,428,966

)

  -   -   (112,686

)

  - 

Convertible preferred stock dividends

  -   -   -   (198,033

)

Net loss available to common stockholders

 $(1,829,567

)

 $(3,070,281

)

 $(5,058,818

)

 $(7,115,771

)

 $(3,293,552

)

 $(1,829,567

)

 $(8,349,229

)

 $(5,058,818

)

                                

Basic and Diluted Loss per Common Share attributable to common stockholders

 $(0.13

)

 $(0.23

)

 $(0.36

)

 $(0.66

)

Basic and Diluted Loss per Common Share

 $(0.06

)

 $(0.13

)

 $(0.28

)

 $(0.36

)

                                

Weighted Average Shares Outstanding:

                                

Basic and Diluted

  14,387,467   13,145,301   14,163,120   10,810,103   51,486,756   14,387,467   29,305,427   14,163,120 

 

The accompanying notes to the condensed consolidated financial statements are an integral part of these statements.

 


4

 

BIO-key International, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

 

 

Series A-1

Preferred Stock

  

Series B-1

Preferred Stock

  

Common Stock

  

Additional

Paid-in

  

Accumulated

      

Common Stock

  

Additional

Paid-in

  

Accumulated

     
 

Shares

  

Amount

  

Shares

  

Amount

  

Shares

  

Amount

  

Capital

  

Deficit

  

Total

  

Shares

  

Amount

  

Capital

  

Deficit

  

Total

 

Balance as of December 31, 2018

  -  $-   -  $-   13,977,868  $1,398  $85,599,140  $(75,134,316

)

 $10,466,222 

Issuance of common stock for directors’ fees

  -   -   -   -   13,820   1   16,505   -   16,506 

Balance as of January 1, 2020

  14,411,432  $1,441  $87,436,402  $(89,723,016

)

 $(2,285,173

)

Issuance of common stock pursuant to securities purchase agreements

  700,000   70   1,032,430   -   1,032,500 

Commitment fee adjustment

  -   -   (900,000

)

  -   (900,000

)

Beneficial conversion feature

  -   -   641,215   -   641,215 

Issuance of common stock pursuant to warrant exercises

  972,000   97   1,457,903   -   1,458,000 

Issuance of common stock for conversion of convertible note payable

  2,307,690   231   1,499,769   -   1,500,000 

Deemed dividends related to down-round features

  -   -   112,686   (112,686

)

  - 

Share-based compensation

  -   -   -   -   -   -   509,528   -   509,528   -   -   512,719   -   512,719 

Net loss

  -   -   -   -   -   -   -   (1,803,508

)

  (1,803,508

)

  -   -   -   (3,370,282

)

  (3,370,282

)

Balance as of March 31, 2019

  -  $-   -  $-   13,991,688  $1,399  $86,125,173  $(76,937,824

)

 $9,188,748 

Balance as of March 31, 2020

  18,391,122  $1,839  $91,793,124  $(93,205,984

)

 $(1,411,021

)

Issuance of common stock for directors’ fees

  -   -   -   -   4,235   -   5,505   -   5,505   17,140   2   15,005   -   15,007 

Issuance of common stock for commitment fees

  -   -   -   -   300,000   30   449,970   -   450,000 

Commitment fee adjustment

  -   -   -   -   -   -   (270,000

)

  -   (270,000

)

Issuance of common stock for pursuant to securities purchase agreements

  251,518   25   145,308   -   145,333 

Warrants issued with convertible notes

  -   -   1,388,339   -   1,388,339 

Warrant issued for consulting fees

  -   -   94,655   -   94,655 

Legal and commitment fees

  -   -   (199,328

)

  -   (199,328

)

Issuance of common stock for conversion of convertible note payable

  3,521,535   352   2,288,648   -   2,289,000 

Share-based compensation

  -   -   -   -   -   -   125,549   -   125,549   -   -   33,177   -   33,177 

Net loss

  -   -   -   -   -   -   -   (1,425,743

)

  (1,425,743

)

  -   -   -   (1,572,709

)

  (1,572,709

)

Balance as of June 30, 2019

  -  $-   -  $-   14,295,923  $1,429  $86,436,197  $(78,363,567

)

 $8,074,059 

Balance as of June 30, 2020

  22,181,315  $2,218  $95,558,928  $(94,778,693

)

 $782,453 

Issuance of common stock for directors’ fees

  -   -   -   -   6,111   1   6,500   -   6,501   10,328   1   7,002   -   7,003 

Issuance of common stock for commitment fees

  -   -   -   -   276,667   28   414,972   -   415,000 

Issuance of common stock pursuant to public offering

  34,114,500   3,411   22,171,014   -   22,174,425 

Commitment fee adjustment

  -   -   -   -   (180,000

)

  (18

)

  18   -   -   (600,000

)

  (60

)

  60   -   - 

Warrant debt discount valuation

                          595,662   -   595,662 

Issuance of common stock pursuant to warrant exercises

  6,364,300   636   4,136,159   -   4,136,795 

Warrant issued for consulting fees

  -   -   12,921   -   12,921 

Issuance of restricted common stock to employees

  306,000   31   (31

)

  -   - 

Legal and commitment fees

  -   -   -   -   -   -   (272,985

)

  -   (272,985

)

  -   -   (2,171,896

)

  -   (2,171,896

)

Share-based compensation

  -   -   -   -   -   -   130,600   -   130,600   -   -   34,306   -   34,306 

Net loss

  -   -   -   -   -   -   -   (1,829,567

)

  (1,829,567

)

  -   -   -   (3,293,552

)

  (3,293,552

)

Balance as of September 30, 2019

  -  $-   -  $-   14,398,701  $1,440  $87,310,964  $(80,193,134

)

 $7,119,270 

Balance as of September 30, 2020

  62,376,443  $6,237  $119,748,463  $(98,072,245

)

 $21,682,455 

 

The accompanying notes to the condensed consolidated financial statements are an integral part of these statements. 

 


5

 

BIO-key International, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited)

 

  

Series A-1

Preferred Stock

  

Series B-1

Preferred Stock

  

Common Stock

  

Additional

Paid-in

  

Accumulated

     
  

Shares

  

Amount

  

Shares

  

Amount

  

Shares

  

Amount

  

Capital

  

Deficit

  

Total

 

Balance as of December 31, 2017

  62,596  $6   105,000  $11   7,691,324  $769  $80,829,001  $(67,076,492

)

 $13,753,295 

Adoption of ASC 606

  -   -   -   -   -   -   -   240,017   240,017 

Issuance of common stock for directors’ fees

  -   -   -   -   8,421   1   16,512   -   16,513 

Dividends declared on preferred stock

  -   -   -   -   -   -   (156,162

)

  -   (156,162

)

Conversion of B-1 preferred stock to common stock

  -   -   (60,420

)

  (6

)

  1,678,334   168   (162

)

  -   - 

Conversion of dividends payable on B-1 preferred stock

  -   -   -   -   115,857   11   417,072   -   417,083 

Share-based compensation

  -   -   -   -   -   -   533,421   -   533,421 

Net loss

  -   -   -   -   -   -   -   (2,191,992

)

  (2,191,992

)

Balance as of March 31, 2018

  62,596  $6   44,580  $5   9,493,936  $949  $81,639,682  $(69,028,467

)

 $12,612,175 

Issuance of common stock for directors’ fees

  -   -   -   -   2,683   1   6,508   -   6,509 

Dividends declared on preferred stock

  -   -   -   -   -   -   (41,871

)

  -   (41,871

)

Conversion of A-1 preferred stock to common stock

  (62,596

)

  (6

)

  -   -   1,738,778   174   (168

)

  -   - 

Conversion of dividends payable on A-1 preferred stock

  -   -   -   -   98,893   10   356,005   -   356,015 

Conversion of B-1 preferred stock to common stock

  -   -   (44,580

)

  (5

)

  1,238,334   123   (118

)

  -   - 

Conversion of dividends payable on B-1 preferred stock

  -   -   -   -   15,373   2   55,339   -   55,341 

Legal fees

  -   -   -   -   -   -   (15,212

)

  -   (15,212

)

Share-based compensation

  -   -   -   -   -   -   143,034   -   143,034 

Net loss

  -   -   -   -   -   -   -   (1,655,465

)

  (1,655,465

)

Rounding

  -   -   -   -   -   -   -   1   1 

Balance as of June 30, 2018

  -  $-   -  $-   12,587,997  $1,259  $82,143,199  $(70,683,931

)

 $11,460,527 

Issuance of common stock for directors’ fees

  -   -   -   -   4,161   -   7,509   -   7,509 

Issuance of common stock pursuant to securities purchase agreement

  -   -   -   -   1,380,000   138   2,069,862   -   2,070,000 

Deemed dividend related to down-round features

  -   -   -   -   -   -   1,428,966   (1,428,966)  - 

Legal fees

  -   -   -   -   -   -   (294,776

)

  -   (294,776

)

Share-based compensation

  -   -   -   -   -   -   188,837   -   188,837 

Net loss

  -   -   -   -   -   -   -   (1,641,315

)

  (1,641,315

)

Rounding

  -   -   -   -   -   1   -   (1)  - 

Balance as of September 30, 2018

  -  $-   -  $-   13,972,158  $1,398  $85,543,597  $(73,754,213

)

 $11,790,782 
  

Common Stock

  

Additional

Paid-in

  

Accumulated

     
  

Shares

  

Amount

  

Capital

  

Deficit

  

Total

 

Balance as of January 1, 2019

  13,977,868  $1,398  $85,599,140  $(75,134,316

)

 $10,466,222 

Issuance of common stock for directors’ fees

  13,820   1   16,505   -   16,506 

Share-based compensation

  -   -   509,528   -   509,528 

Net loss

  -   -   -   (1,803,508

)

  (1,803,508

)

Balance as of March 31, 2019

  13,991,688  $1,399  $86,125,173  $(76,937,824

)

 $9,188,748 

Issuance of common stock for directors’ fees

  4,235   -   5,505   -   5,505 

Issuance of common stock pursuant to securities purchase agreements

  300,000   30   449,970

 

  -   450,000 

Commitment fee adjustment

  -   -   (270,000

)

  -   (270,000

)

Share-based compensation

  -   -   125,549   -   125,549 

Net loss

  -   -   -   (1,425,743

)

  (1,425,743

)

Balance as of June 30, 2019

  14,295,923  $1,429  $86,436,197  $(78,363,567

)

 $8,074,059 

Issuance of common stock for directors’ fees

  6,111   1   6,500   -   6,501 

Issuance of common stock pursuant to securities purchase agreement

  276,667   28   414,972   -   415,000 

Commitment fee adjustment

  (180,000

)

  (18

)

  18   -   - 

Warrant debt discount valuation

  -   -   595,662   -   595,662 

Legal and commitment fees

  -   -   (272,985

)

  -   (272,985

)

Share-based compensation

  -   -   130,600   -   130,600 

Net loss

  -   -   -   (1,829,567

)

  (1,829,567

)

Balance as of September 30, 2019

  14,398,701  $1,440  $87,310,964  $(80,193,134

)

 $7,119,270 

 

The accompanying notes to the condensed consolidated financial statements are an integral part of these statements.

 


6

 

BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

Nine Months Ended

September 30,

  

Nine Months Ended

September 30,

 
 

2019

  

2018

  

2020

  

2019

 
                

CASH FLOW FROM OPERATING ACTIVITIES:

                

Net loss

 $(5,058,818

)

 $(5,488,772

)

 $(8,236,543

)

 $(5,058,818

)

Adjustments to reconcile net loss to cash used for operating activities:

                

Depreciation

  59,717   69,083   59,129   59,717 

Amortization of intangible assets

  9,941   12,281   17,215   9,941 

Amortization of resalable software license rights

  843,287   1,978,349   -   843,287 

Amortization of debt discount

  288,774   -   1,416,040   288,774 

Amortization of capitalized contract costs

  102,839   90,518   111,467   102,839 

Amortization of debt issuance costs

  311,718   -   2,166,650   311,718 

Operating leases right-of-use assets

  151,325   (8,946

)

Loss on extinguishment of debt

  499,076   - 

Amortization of beneficial conversion feature

  641,215   - 

Share-based and warrant compensation for employees and consultants

  765,677   865,291   687,778   765,677 

Stock based directors’ fees

  28,512   30,530 

Share-based directors’ fees

  22,010   28,512 

Change in operating assets and liabilities:

                

Accounts receivable

  800,698   2,262,423   (181,588

)

  800,698 

Due from factor

  5,980   29,464   47,679   5,980 

Operating leases right-of-use assets

  (8,946

)

  - 

Capitalized contract costs

  (38,597

)

  (183,569

)

  (29,808

)

  (38,597

)

Inventory

  27,662   (97,306

)

  29,723   27,662 

Resalable software license rights

  40,857   18,111   5,044   40,857 

Prepaid expenses and other

  (45,000

)

  (20,243

)

  (86,137

)

  (45,000

)

Accounts payable

  15,398   (129,445

)

  (530,011

)

  15,398 

Accrued liabilities

  (69,691

)

  (102,422

)

  (193,146

)

  (69,691

)

Deferred revenue

  26,112   (252,128

)

  (135,707

)

  26,112 

Operating lease liabilities

  14,667   -   (147,480

)

  14,667 

Net cash used for operating activities

  (1,879,213

)

  (917,835

)

  (3,686,069

)

  (1,879,213

)

CASH FLOWS FROM INVESTING ACTIVITIES:

                

Issuance of note receivable

  (295,000

)

  - 

Purchase of PistolStar

  (2,000,000

)

  - 

Cash acquired from purchase of PistolStar

  100,747   - 

Proceeds from maturity of debt security

  512,821   - 

Purchase of intangible assets

  (1,736

)

  -   -   (1,736

)

Purchase of debt security

  (516,121

)

  (512,821

)

Capital expenditures

  (28,753

)

  (82,143

)

  (6,094

)

  (28,753

)

Purchase of investment – non-marketable security

  (512,821

)

  - 

Net cash used for investing activities

  (543,310

)

  (82,143

)

  (2,203,647

)

  (543,310

)

CASH FLOW FROM FINANCING ACTIVITIES:

                

Proceeds from Issuance of convertible notes

  3,217,000   - 

Proceeds from issuance of convertible notes

  3,958,000   3,217,000 

Repayment of convertible notes

  (707,000

)

  -   (4,509,250

)

  (707,000

)

Proceeds from Issuance of common stock

  -   1,875,100 

Costs to issue notes, common and preferred stock

  (333,180

)

  (115,088

)

Proceeds from issuance of common stock

  22,174,425   -��

Proceeds from the exercise of warrants

  5,594,795   - 

Costs to issue notes, common stock and warrants

  (2,693,022

)

  (333,180

)

Repayment of note payable - PistolStar

  (130,000

)

  - 

Net repayments of loans payable to related parties

  (188,737

)

  - 

Net cash provided by financing activities

  2,176,820   1,760,012   24,206,211   2,176,820 

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

  (245,703

)

  760,034 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

  18,316,495   (245,703

)

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

  323,943   288,721   79,013   323,943 

CASH AND CASH EQUIVALENTS, END OF PERIOD

 $78,240  $1,048,755  $18,395,508  $78,240 

 

The accompanying notes to the condensed consolidated financial statements are an integral part of these statements.  

 


7

 

BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION

 

  

Nine Months Ended

September 30,

 
  

2019

  

2018

 
         

Cash paid for:

        

Interest

 $-  $- 

Income taxes

 $-  $- 
         

Noncash Investing and financing activities

        

Accrual of unpaid dividends on preferred stock

 $-  $198,033 

Conversion of A-1 preferred dividends payable to common stock

 $-  $356,015 

Conversion of A-1 preferred stock to common stock

 $-  $6,259,600 

Conversion of B-1 preferred dividends payable to common stock

 $-  $472,426 

Conversion of B-1 preferred stock to common stock

 $-  $10,500,000 

Deemed dividend from trigger of anti-dilution provision feature

 $-  $1,428,966 

Right-of-use asset addition under ASC 842

 $719,812  $- 

Operating lease liabilities under ASC 842

 $707,217  $- 

Share based loan commitment fees

 $595,000  $- 

Debt discount issued with convertible note

 $550,000  $- 

Warrant debt discount valuation

 $595,662  $- 
  

Nine Months Ended

September 30,

 
  

2020

  

2019

 
         

Cash paid for:

        

Interest

 $99,426  $- 

Income taxes

 $-  $- 
         

Noncash Investing and financing activities

        

Accounts receivable acquired from PistolStar

 $184,792  $- 

Prepaid expenses acquired from PistolStar

 $9,485  $- 

Equipment acquired from PistolStar

 $36,467  $- 

Intangible assets acquired from PistolStar

 $1,480,000  $- 

Goodwill related to PistolStar acquisition

 $1,154,526  $- 

Issuance of note payable for PistolStar acquisition, net of working capital adjustment

 $356,000  $- 

Accrued expenses acquired from PistolStar

 $20,017  $- 

Deferred revenue acquired from PistolStar

 $590,000  $- 

Issuance of common stock pursuant to securities purchase agreements

 $277,833  $595,000 

Warrants issued with convertible notes

 $1,388,339  $595,662 

Issuance of common stock for conversion of note payable

 $3,789,000  $- 

Beneficial conversion feature

 $641,215  $- 

Deemed dividends related to down-round features

 $112,686  $- 

Right-of-use asset addition under ASC 842

 $141,761  $719,812 

Operating lease liabilities under ASC 842

 $141,761  $707,217 

 

The accompanying notes to the condensed consolidated financial statements are an integral part of these statements.  

 


8

 

BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

September 30, 20192020 (Unaudited)

 

 

 

1.

NATURE OF BUSINESS AND BASIS OF PRESENTATION

 

Nature of Business

 

The Company, founded in 1993, develops and markets proprietary fingerprint identification biometric technology and software solutions. The Company was a pioneer in developing automated, finger identification technology that supplements or compliments other methods of identification and verification, such as personal inspection identification, passwords, tokens, keys, smart cards, ID cards, PKI, credit card, passports, driver’s licenses, OTP or other form of possession or knowledge-based credentialing. Additionally, advanced BIO-key® technology has been, and is, used to improve both the accuracy and speed of competing finger-based biometrics.

 

Basis of Presentation

 

The accompanying unaudited interim condensed consolidated financial statements include the accounts of BIO-key International, Inc. and its wholly-owned subsidiarysubsidiaries (collectively, the “Company” or “BIO-key”) and are stated in conformity with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). The operating results for interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year. Pursuant to such rules and regulations, certain financial information and notefootnote disclosures normally included in the financial statements have been condensed or omitted. Significant intercompany accounts and transactions have been eliminated in consolidation.

 

In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all necessary adjustments, consisting only of those of a recurring nature, and disclosures to present fairly the Company’s financial position and the results of its operations and cash flows for the periods presented. The balance sheet at September 30,December 31, 2019 was derived from the audited financial statements, but does not include all of the disclosures required by accounting principles generally accepted in the United States of America. These unaudited interim condensed consolidated financial statements should be read in conjunction with the financial statements and the related notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018,2019, filed with the SEC on April 1, 2019. May 14, 2020, and the 8-K/A disclosing the financial statements of PistolStar, Inc. (“PistolStar”) filed on July 28, 2020.

 

UpdatedNew Significant Accounting Policies

LeasesBusiness Combinations

In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-02, “Leases” (Topic 842), as amended (ASC 842).  The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months and classify as either operating or finance leases.  We adopted this standard effective January 1, 2019 using the modified retrospective approach for all leases entered into before the effective date.  Adoption of the ASC 842 had a significant effect on our balance sheet resulting in increased non-current assets and increased current and non-current liabilities.  There was no impact to retained earnings upon adoption of the new standard. We did not have any finance leases (formerly referred to as capital leases prior to the adoption of ASC 842), therefore there was no change in accounting treatment required.  For comparability purposes, the Company will continue to comply with the previous disclosure requirements in accordance with the existing lease guidance and prior periods are not restated.

The Company elected the package of practical expedients as permitted under the transition guidance, which allowed us: (1) to carry forward the historical lease classification; (2) not to reassess whether expired or existing contracts are or contain leases; and, (3) not to reassess the treatment of initial direct costs for existing leases.

In accordance with ASC 842,805, Business Combinations (ASC 805), the Company recognizes the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values. Determining these fair values requires management to make significant estimates and assumptions, especially with respect to intangible assets.

The Company recognizes identifiable assets acquired and liabilities assumed at their acquisition date fair value. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net acquisition date fair value of the assets acquired and the liabilities assumed and represents the expected future economic benefits arising from other assets acquired that are not individually identified and separately recognized. While the Company uses its best estimates and assumptions as part of the purchase price allocation process to accurately value assets acquired and liabilities assumed at the inceptionacquisition date, its estimates are inherently uncertain and subject to refinement. Assumptions may be incomplete or inaccurate, and unanticipated events or circumstances may occur, which may affect the accuracy or validity of an arrangement,such assumptions, estimates or actual results. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill to the extent that it identifies adjustments to the preliminary purchase price allocation. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations.

Goodwill and acquired intangible assets

Goodwill is not amortized, but is evaluated for impairment annually, or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. The Company has determined that there is a single reporting unit for the purpose of conducting this goodwill impairment assessment. For purposes of assessing potential impairment, the Company estimates the fair value of the reporting unit, based on the Company’s market capitalization, and compares this amount to the carrying value of the reporting unit. If the Company determines whetherthat the arrangement is or containscarrying value of the reporting unit exceeds its fair value, an impairment charge would be required. The annual goodwill impairment test will be performed as of December 31st of each year. To date, the Company has not identified any impairment to goodwill.

9

Intangible assets acquired in a leasebusiness combination are recorded at their estimated fair values at the date of acquisition. The Company amortizes acquired definite-lived intangible assets over their estimated useful lives based on the unique facts and circumstances present and the classificationpattern of consumption of the lease including whether the contract involves the use ofeconomic benefits or, if that pattern cannot be readily determined, on a distinct identified asset, whether we obtain the right to substantially all the economic benefit from the use of the asset, and whether we have the right to direct the use of the asset. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (ROU) assets, lease liabilities and, if applicable, long-term lease liabilities. The Company has elected not to recognize on the balance sheet leases with terms of one year or less under practical expedient in paragraph ASC 842-20-25-2. For contracts with lease and non-lease components, the Company has elected not to allocate the contract consideration and to account for the lease and non-lease components as a single lease component.straight-line basis.


Lease liabilities and their corresponding ROU assets are recorded based on the present value of lease payments over the expected lease term. The implicit rate within our operating leases are generally not determinable and, therefore, the Company uses the incremental borrowing rate at the lease commencement date to determine the present value of lease payments. The determination of the Company’s incremental borrowing rate requires judgment. The Company determines the incremental borrowing rate for each lease using our estimated borrowing rate, adjusted for various factors including level of collateralization, term and currency to align with the terms of the lease. The operating lease ROU asset also includes any lease prepayments, offset by lease incentives.

An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain we will exercise that option. An option to terminate is considered unless it is reasonably certain we will not exercise the option.

For periods prior to the adoption of ASC 842, the Company recorded rent expense based on the term of the related lease. The expense recognition for operating leases under ASC 842 is substantially consistent with prior guidance. As a result, there are no significant differences in our results of operations presented.

The impact of the adoption of ASC 842 on the balance sheet was:

  

As reported

  

Adoption of ASC

  

Balance

 
  

December 31,

2018

  

842 - increase

(decrease)

  

January 1,

2019

 

Operating lease right-of-use assets

 $-  $602,937  $602,937 

Prepaid expenses and other

 $150,811  $(12,595

)

 $138,216 

Total assets

 $11,692,332  $590,342  $12,282,674 

Operating lease liabilities, current portion

 $-  $135,519  $135,519 

Operating lease liabilities, net of current portion

 $-  $454,823  $454,823 

Total liabilities

 $1,226,110  $590,342  $1,816,452 

Total liabilities and stockholders’ equity

 $11,692,332  $590,342  $12,282,674 

 

 

Recently Issued Accounting Pronouncements

  

In August 2018, the FASB issued ASU No. 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU 2018-15”). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update to the standard is effective for interim and annual periods beginning after December 15, 2019, with early adoption permitted. Entities can choose to adopt the ASU 2018-15 prospectively or retrospectively. The Company is currently assessing the impacthas assessed that ASU 2018-15 willcurrently does not have a material impact on its consolidated financial statements.

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), referred to herein as ASU 2016-13, which significantly changes how entities will account for credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. ASU 2016-13 replaces the existing incurred loss model with an expected credit loss model that requires entities to estimate an expected lifetime credit loss on most financial assets and certain other instruments. Under ASU 2016-13 credit impairment is recognized as an allowance for credit losses, rather than as a direct write-down of the amortized cost basis of a financial asset. The impairment allowance is a valuation account deducted from the amortized cost basis of financial assets to present the net amount expected to be collected on the financial asset. Once the new pronouncement is adopted by the Company, the allowance for credit losses must be adjusted for management’s current estimate at each reporting date. The new guidance provides no threshold for recognition of impairment allowance. Therefore, entities must also measure expected credit losses on assets that have a low risk of loss. For instance, trade receivables that are either current or not yet due may not require an allowance reserve under currently generally accepted accounting principles, but under the new standard, the Company will have to estimate an allowance for expected credit losses on trade receivables under ASU 2016-13. ASU 2016-13 is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2019.2022 for smaller reporting companies. Early adoption is permitted. The Company is currently assessing the impact ASU 2016-13 will have on its condensed consolidated financial statements.

 

Management does not believe that any other recently issued, but not yet effective, accounting standard if currently adopted would have a material effect on the accompanying consolidated financial statements.

Reclassification

Reclassifications occurred to certain prior year amounts in order to conform to the current year classifications including segregating the hardware revenues. The reclassifications have no effect on the reported net loss.


10

 

 

2.

GOING CONCERN

 

The Company has incurred significant losses to date and at September 30, 20192020 had an accumulated deficit of approximately $80$98 million. In addition, broad commercial acceptance of the Company’s technology is critical to the Company’s success and ability to generate future revenues. At September 30, 2019,2020, the Company’s total cash and cash equivalents were approximately $78,000,$18.4 million, as compared to approximately $324,000$79,000 at December 31, 2018.2019.

 

The Company has financed operations in the past through access to the capital markets by issuing secured and convertible debt securities, convertible preferred stock, common stock, and through factoring receivables. The Company estimates that it currently requires approximately $537,000$680,000 per month to conduct operations, a monthly amount that it has been unable to achieve consistently through revenue generation.

 

IfIn July of 2020, the Company is unableraised approximately $22.7 million, after deducting the underwriting discounts and commissions and estimated offering expenses.  The Company used approximately $4.2 million of the net proceeds of the offering to generate sufficientsatisfy all outstanding amounts due under convertible promissory notes previously issued to Lind Global Macro Fund, L.P. 

Due to several factors, including the Company’s history of losses and limited revenue, to meet its goals, it will need to obtain additional third-party financing to (i) conduct the sales, marketing and technical support necessary to execute its plan to substantially grow operations, increase revenue, and serve a significant customer base; and (ii) provide working capital. No assurance can be given that any form of additional financing will be available on terms acceptableindependent auditors have included an explanatory paragraph in their audit opinion related to the Company, that adequate financing will be obtained by the Company, in order to meet its needs, or that such financing would not be dilutive to existing shareholders.

The accompanyingCompany’s 2019 annual financial statements have been prepared in conformity with accounting principles generally accepted inas to the United States of America ("GAAP"), which contemplate continuation of the Company as a going concern, and assumes continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The matters described in the preceding paragraphs raise substantial doubt about the Company’s ability to continue as a going concern. RecoverabilityThe Company’s long-term viability and growth will depend upon the successful commercialization of a major portionits technologies and expansion of operations, and to pursue merger or acquisition candidates.  It is expected that the Company’s independent auditors will reevaluate its going concern qualification based on the Company’s financial position and performance in future periods. As of the recorded asset amounts shown indate of the accompanying balance sheet is dependent uponfiling of this report, management believes the Company has adequate cash to support the Company’s ability to meet its financing requirements on a continuing basis, and become profitable in its future operations. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.activities through fiscal year 2021.

 

 

 

3.

REVENUE FROM CONTRACTS WITH CUSTOMERS

 

The Company adopted ASC 606 on January 1, 2018 using the modified retrospective method for all contracts not completed as of the date of adoption. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. To achieve this core principle, the Company applies the following five steps:

 

Identify the contract with a customer

Identify the performance obligations in the contract

Determine the transaction price

Allocate the transaction price to performance obligations in the contract

Recognize revenue when or as the Company satisfies a performance obligation

  


11

 

Disaggregation of Revenue

 

The following table summarizes revenue from contracts with customers for the three month periods ended:

 

 

North

America

  

South

America

  

EMEA*

  

Asia

  

September 30,

2019

  

North

America

  

South

America

  

EMEA*

  

Asia

  

September 30,

2020

 
                                        

License fees

 $50,400  $43,000  $4,168  $704  $98,272  $339,747  $-  $6,732  $-  $346,479 

Hardware

  98,995   -   14,759   3,316   117,070   103,511   -   1,800   -   105,311 

Support and Maintenance

  197,814   845   20,433   5,000   224,092 

Professional services

  8,280   -   3,000   2,000   13,280 

Services

  450,994   13,800   22,893   3,848   491,535 

Total Revenues

 $355,489  $43,845  $42,360  $11,020  $452,714  $894,252  $13,800  $31,425  $3,848  $943,325 

 

 

 

North

America

  

South

America

  

EMEA*

  

Asia

  

September 30,

2018

  

North

America

  

South

America

  

EMEA*

  

Asia

  

September 30,

2019

 
                                        

License fees

 $116,985  $2,000  $91,666  $-  $210,651  $50,400  $43,000  $4,168  $704  $98,272 

Hardware

  115,162   160   173,400   14,638   303,360   98,995   -   14,759   3,316   117,070 

Support and Maintenance

  196,969   -   22,650   -   219,619 

Professional services

  6,120   -   -   -   6,120 

Services

  206,094   845   23,433   7,000   237,372 

Total Revenues

 $435,236  $2,160  $287,716  $14,638  $739,750  $355,489  $43,845  $42,360  $11,020  $452,714 

 

 

The following table summarizes revenue from contracts with customers for the nine month periods ended:

 

 

North

America

  

South

America

  

EMEA*

  

Asia

  

September 30,

2019

  

North

America

  

South

America

  

EMEA*

  

Asia

  

September 30,

2020

 
                                        

License fees

 $97,408  $43,000  $31,668  $69,704  $241,780  $528,524  $-  $6,732  $70,110  $605,366 

Hardware

  269,393   12,636   342,304   155,632   779,965   208,192   -   1,800   29,033   239,025 

Support and Maintenance

  590,753   8,252   79,440   13,501   691,946 

Professional services

  12,029   -   3,000   4,000   19,029 

Services

  857,156   14,550   37,594   19,261   928,561 

Total Revenues

 $969,583  $63,888  $456,412  $242,837  $1,732,720  $1,593,872  $14,550  $46,126  $118,404  $1,772,952 

 

 

 

North

America

  

South

America

  

EMEA*

  

Asia

  

September 30,

2018

  

North

America

  

South

America

  

EMEA*

  

Asia

  

September 30,

2019

 
                                        

License fees

 $247,105  $32,000  $188,516  $-  $467,621  $97,408  $43,000  $31,668  $69,704  $241,780 

Hardware

  335,248   53,200   398,474   297,494   1,084,416   269,393   12,636   342,304   155,632   779,965 

Support and Maintenance

  600,487   16   43,866   16,970   661,339 

Professional services

  113,970   -   2,000   -   115,970 

Services

  602,782   8,252   82,440   17,501   710,975 

Total Revenues

 $1,296,810  $85,216  $632,856  $314,464  $2,329,346  $969,583  $63,888  $456,412  $242,837  $1,732,720 

 

*EMEA – Europe, Middle East, Africa

 

All of the Company's performance obligations, and associated revenue, are generally transferred to customers at a point in time, with the exception of support and maintenance, and professional services, which are generally transferred to the customer over time.

 

Software licenses

Software license revenue consist of fees for perpetual softwareand subscription licenses for one or more of the Company’s biometric fingerprint solutions. Revenue is recognized at a point in time once the software is available to the customer for download. Software license contracts are generally invoiced in full on execution of the arrangement.

 


12

 

Hardware

Hardware revenue consists of fees for associated equipment sold with or without a software license arrangement, such as servers, locks and fingerprint readers. Customers are not obligated to buy third party hardware from the Company, and may procure these items from a number of suppliers. Revenue is recognized at a point in time once the hardware is shipped to the customer. Hardware items are generally invoiced in full on execution of the arrangement.

 

Support and Maintenance

Support and maintenanceMaintenance revenue consists of fees for unspecified upgrades, telephone assistance and bug fixes. The Company satisfies its supportSupport and maintenanceMaintenance performance obligation by providing “stand-ready” assistance as required over the contract period. The Company records deferred revenue (contract liability) at time of invoice until the contracts term occurs. Revenue is recognized over time on a ratable basis over the contract term. Support and maintenanceMaintenance contracts are upone to one yearfive years in length and are generally invoiced either annually or quarterly in advance.advance at the beginning of the term. Support and Maintenance revenue for subscription licenses is carved out of the total license cost at 18% and recognized on a ratable basis over the license term.

 

Professional Services

Professional services revenues consist primarily of fees for deployment and optimization services, as well as training. The majority of the Company’s consulting contracts are billed on a time and materials basis, and revenue is recognized based on the amount billable to the customer in accordance with practical expedient ASC 606-10-55-18. For other professional services contracts, the Company utilizes an input method and recognizes revenue based on labor hours expended to date relative to the total labor hours expected to be required to satisfy its performance obligation.

 

Contracts with Multiple Performance Obligations

Some contracts with customers contain multiple performance obligations. For these contracts, the Company accounts for individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis.  The standalone selling prices are determined based on overall pricing objectives, taking into consideration market conditions and other factors, including the value of the contracts, the cloud applications sold, customer demographics, geographic locations, and the number and types of users within the contracts.

 

The Company considered several factors in determining that control transfers to the customer upon shipment of hardware and availability of download of software.  These factors include that legal title transfers to the customer, the Company has a present right to payment, and the customer has assumed the risks and rewards of ownership.

 

Accounts receivable from customers are typically due within 30 days of invoicing.  The Company does not record a reserve for product returns or warranties as amounts are deemed immaterial based on historical experience.

 

Costs to Obtain and Fulfill a Contract

Costs to obtain and fulfill a contract are predominantly sales commissions earned by the sales force and are considered incremental and recoverable costs of obtaining a contract with a customer. These costs are deferred and then amortized over a period of benefit determined to be four years. These costs are included as capitalized contract costs on the balance sheet. The period of benefit was determined by taking into consideration customer contracts, technology, and other factors based on historical evidence. Amortization expense is included in selling, general and administrative expenses in the accompanying condensed consolidated statements of operations.

  

Revenue recognized during the three and nine months ended September 30, 2019 from amounts included in deferred revenue at the beginning of the period was approximately $89,000 and $200,000, respectively. The Company did not recognize any revenue from performance obligations satisfied in prior periods. Total deferred revenue (contract liability) was $222,721 and $196,609 at September 30, 2019 and December 31, 2018, respectively.

Transaction Price Allocated to the Remaining Performance Obligations

ASC 606 requires that the Company disclose the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as at September 30, 2019.2020. The guidance provides certain practical expedients that limit this requirement, which the Company’s contracts meet as follows:

 

 

The performance obligation is part of a contract that has an original expected duration of one year or less, in accordance with ASC 606-10-50-14.

 

At September 30, 20192020, deferred revenue represents ourthe remaining performance obligations related to support and maintenance, all of which is expected to be recognized withinfrom one year.year to five years.

Revenue recognized during the three and nine months ended September 30, 2020 from amounts included in deferred revenue at the beginning of the period was approximately $94,000 and $202,000, respectively. Revenue recognized during the three and nine months ended September 30, 2019 from the amounts included in the deferred revenue at the beginning of the period was approximately $89,000 and $200,000, respectively. The Company did not recognize any revenue from performance obligations satisfied in prior periods. Total deferred revenue (contract liability) was $813,505 and $359,212 at September 30, 2020 and December 31, 2019, respectively.

 


13

 

 

4.

PistolStar, Inc. acquisition

On June 30, 2020, the Company acquired PistolStar, Inc., a private company based in the United States, which provides enterprise-ready identity access management solutions, including multi-factor authentication, identity-as-a-service, single sign-on and self-service password reset to commercial, government and education customers throughout the United States and internationally.

From April 10, 2020 until the Company acquired PistolStar, it licensed PortalGuard®, PistolStar’s authentication software, which the Company combines with its biometric authentication solutions offered to existing and prospective customers.

The total purchase price of $2.5 million included cash payments of $2.0 million and the issuance of a $500,000 promissory note. The purchase price is subject to a working capital adjustment, which has been estimated to be a reduction of $108,000.

The acquisition of PistolStar has been accounted for as a business combination and, in accordance with ASC 805,the Company has recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The following table summarizes the preliminary purchase price allocation as of September 30, 2020:

Purchase consideration:

    

Total cash paid, net of acquired cash

 $2,000,000 
4% Promissory note, net of discount of $36,000  464,000 

Working capital adjustment

  (108,000

)

Total purchase price consideration

 $2,356,000 
     

Fair value of assets acquired and liabilities assumed:

    

Cash and cash equivalents

 $100,747 

Accounts receivable

  184,792 

Prepaid expenses and other current assets

  9,485 

Fixed assets

  36,467 

Intangible assets

  1,480,000 

Goodwill

  1,154,526 

Total assets acquired

  2,966,017 
     

Accrued expenses and other current liabilities

  738 

Accrued payroll

  19,279 

Deferred revenue

  590,000 

Total fair value of assets acquired and liabilities assumed

 $2,356,000 

The promissory note, which was issued to the previous owner of PistolStar, carries interest at 4% per annum and is payable in four installments over the 12-month period following the closing.  During the three months ended September 30, 2020, the Company made one payment in the amount of $130,000.

In the three and nine months ended September 30, 2020, acquisition-related expenses were immaterial. Acquisition-related expenses have been included primarily in general and administrative expenses in the condensed consolidated statements of operations. The operating results of PistolStar have been included in the condensed consolidated statements of operations since July 1, 2020.

The significant intangible assets identified in the purchase price allocation discussed above include the Trade Name, Proprietary Software, and Customer Relationships. To value the Trade Name and Proprietary Software, the Company utilized the Relief from Royalty Method, which quantifies the cost savings associated with asset ownership via a discounted cash flow analysis. To value the Customer Relationships, the Company utilized the Excess Earnings Method, which isolates the value of the specific intangible asset by discounting its income stream to present value.

The fair value of the assets acquired and liabilities assumed reflected in the tables above is less than the purchase price, resulting in the recognition of goodwill. The goodwill reflects the value of the synergies the Company expects to realize and the assembled workforce.

The following table presents the preliminary fair values and useful lives of the identifiable intangible assets acquired:

  

Amount

  

Estimated useful life

(in years)

 

Trade Name

 $130,000   15  

Proprietary Software

  420,000   5  

Customer relationships

  930,000  8-10 

Total identifiable intangible assets

 $1,480,000      

14

5.

ACCOUNTS RECEIVABLE

 

Accounts receivable are carried at original amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful receivables by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, and current economic conditions. Accounts receivable are written off when deemed uncollectible.

As a result of the payment delays forfrom a large customer, the Company has reserved $1,720,000 at September 30, 20192020 and December 31, 2018,2019, which represents 100% of the remaining balance owed under the contract, respectively.contract. Recoveries of accounts receivable previously written off are recorded when received. Accounts receivable at September 30, 2019 andAdditionally, the Company sold a license to a Chinese reseller in December 2018. Revenue was recognized in accordance with ASC 606 in the amount of $1.1 million in 2018. As of December 31, 2018 consisted2019, the second payment due to be paid in March 2019 of $555,555 was still outstanding and payable. As of December 31, 2019, the following: Company wrote off the amount directly to bad debt expense as it was determined not to be collectible.

 

 

September 30,

  

December 31,

  

September 30,

  

December 31,

 
 

2019

  

2018

  

2020

  

2019

 
                

Accounts receivable - current

 $787,119  $1,587,817  $506,165  $139,785 

Accounts receivable - non current

  1,720,000   1,720,000   1,720,000   1,720,000 

Total accounts receivable

  2,507,119   3,307,817   2,226,165   1,859,785 

Allowance for doubtful accounts - current

  (13,785

)

  (13,785

)

  (13,785

)

  (13,785

)

Allowance for doubtful accounts - non current

  (1,720,000

)

  (1,720,000

)

  (1,720,000

)

  (1,720,000

)

Total allowance for doubtful accounts

  (1,733,785

)

  (1,733,785

)

  (1,733,785

)

  (1,733,785

)

Accounts receivable, net of allowance for doubtful accounts

 $773,334  $1,574,032  $492,380  $126,000 

 

 

 

5.6.

SHARE BASEDSHARE-BASED COMPENSATION

  

The following table presents share-based compensation expenses for continuing operations included in the Company’s unaudited interim condensed consolidated statements of operations:

 

 

Three Months

Ended

September 30,

  

Three Months

Ended

September 30,

  

Three Months

Ended

September 30,

  

Three Months

Ended

September 30,

 
 

2019

  

2018

  

2020

  

2019

 
                

Selling, general and administrative

 $121,999  $170,758  $51,157  $121,999 

Research, development and engineering

  15,102   25,588   3,073   15,102 
 $137,101  $196,346  $54,230  $137,101 

 

 

 

Nine Months

Ended

September 30,

  

Nine Months

Ended

September 30,

  

Nine Months

Ended

September 30,

  

Nine Months

Ended

September 30,

 
 

2019

  

2018

  

2020

  

2019

 
                

Selling, general and administrative

 $690,612  $770,524  $632,793  $690,612 

Research, development and engineering

  103,577   125,297   76,995   103,577 
 $794,189  $895,821  $709,788  $794,189 

 


15

 

 

6.7.

FACTORING

 

Due from factor consisted of the following as of: 

 

 

September 30,

  

December 31,

  

September 30,

  

December 31,

 
 

2019

  

2018

  

2020

  

2019

 
                

Original invoice value

 $266,386  $221,120  $128,004  $233,005 

Factored amount

  (215,684

)

  (164,438

)

  (64,742

)

  (122,064

)

Balance due from factor

 $50,702  $56,682  $63,262  $110,941 

 

The Company entered into an accounts receivable factoring arrangement with a financial institution (the “Factor”) which has been extended toexpires on October 31, 2020.2021. Pursuant to the terms of the arrangement, the Company, from time to time, sells to the Factor a minimum of $150,000 per quarter of certain of its accounts receivable balances on a non-recourse basis per quarter for credit approved accounts. The Factor remits 35% of the foreign and 75% of the domestic accounts receivable balance to the Company (the “Advance Amount”), with the remaining balance, less fees, forwarded to the Company once the Factor collects the full accounts receivable balance from the customer. In addition, the Company, from time to time, receives over advances from the Factor. Factoring fees range from 2.75% to 15% of the face value of the invoice factored, and are determined by the number of days required for collection of the invoice. The cost of factoring is included in selling, general and administrative expenses. The cost of factoring was as follows:  

 

  

Three Months ended

September 30,

  

Nine Months ended

September 30,

 
  

2019

  

2018

  

2019

  

2018

 
                 

Factoring fees

 $32,891  $43,798  $125,231  $148,012 

 

 

Three Months ended

September 30,

 

 

Nine Months ended

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Factoring fees

 

$

15,934

 

 

$

32,891

 

 

$

81,164

 

 

$

125,231

 

  

 

 

7.8.

NOTE RECEIVABLE

During the quarter, the Company loaned $295,000 as an advance to aid in fulfilling the African contracts. The note does not bear any interest rate if paid within the nine (9) monthly installments beginning December 31, 2020.  The note bears a default rate of 5%.

9.

INVENTORY

 

Inventory is stated at the lower of cost, determined on a first in, first out basis, or net realizable value and consists primarily of fabricated assemblies and finished goods. Inventory is comprised of the following as of: 

 

 

September 30,

  

December 31,

  

September 30,

  

December 31,

 
 

2019

  

2018

  

2020

  

2019

 
                

Finished goods

 $537,219  $496,358  $258,038  $287,761 

Fabricated assemblies

  433,948   502,471   141,358   141,358 

Total inventory

 $971,167  $998,829  $399,396  $429,119 

  

16

 

 

8.10.

RESALABLE SOFTWARE LICENSE RIGHTS

 

On November 11, 2015, the Company entered into a license agreement for the rights to all software and documentation regarding the technology currently known as or offered under the FingerQ name. The license agreement grants the Company the exclusive right to reproduce, create derivative works and distribute copies of the FingerQ software and documentation, create new FingerQ related products, and grant sub-licenses of the licensed technology to end users. The license rights have been granted to the Company in perpetuity, with a stated number of end-user resale sub-licenses allowed under the contract for a total of $12,000,000. The cost of sub-license rights expected to be amortized in the following 12 months is $1,125,000 and is classified as current, with remainder as non-current.

 

The Company originallyinitially determined the software license rights to be a finite lived intangible asset, and estimated that the software license rights shall be economically used over a 10 year10-year period, with a weighting towards the beginning years of that time-frame. The license rights were acquired during the fourth quarter of 2015, but the usage of such rights in the Company’s products was not generally available until January 2017. Accordingly, amortization began in the first quarter of 2017.

 

Through December 31, 2018, the remaining license rights were amortized over the greater of the following amounts: 1) an estimate of the economic use of such license rights, 2) the amount calculated by the straight line method over ten years or 3) the actual cost basis of sales usage of such rights. The Company believes that the economic use model was front-end focused as a majorityAfter re-evaluation of the expected up-taketimeline of the FingerQ technology was predicted to occur during the first 4-5 years of the 10-year life cycle of the product. Based on current sales trends,future license transactions, commencing January 1, 2019, the Company now believes future transactions will be more evenly dispersed over the remaining life cycle of the product, indicating thatchanged its amortization methodology to the greater of the straight-line methodology or actual unit cost per license sold will more closely align the expense with the remaining useful life of the product. The change in amortization was effective beginning on January 1, 2019 based on the net remaining software license rights balance.licenses as of January 1, 2019. The Company believes categorizingcategorized the amortization expense under Cost of Sales as it more closely reflectsreflected the nature of the license right arrangement and the use of the technology.

 


During the fourth quarter of 2019, the Company re-evaluated the recoverability of the carrying amount of the balance of license rights, and concluded that there were no significant undiscounted cash flows expected to be generated from the future sale of the license rights. Accordingly, an impairment charge of $6,957,516 was recorded in the fourth quarter of 2019, which reduced the carrying amount of the FingerQ license rights to zero. Throughout 2019, the Company attempted to sell the technology into the mobile market in Asia, but due to, among other things, the trade tension between the US and China, management concluded that the future amortization would not represent an accurate cost to the ongoing business, without corresponding revenue. A total of $281,250$281,137 and $660,000$113 was charged to cost of sales during the three-month periodsperiod ended September 30, 2019 for amortization and 2018, respectively, and of this amount $113 and $210, represent the cost basis of the actual sales, respectively. A total of $843,750$843,287 and $1,980,000$463 was charged to cost of sales during the nine-month periodsperiod ended September 30, 2019 for amortization and 2018, respectively and of this amount $463 and $1,651 represent the cost basis of the actual sales, respectively.  Since the license purchase, a cumulative amount of $5,042,346 has been charged to cost of sales, with a carrying balance of $6,957,654 as of September 30, 2019.

The Company's change in methodology was determined to be a change in accounting estimate that is effected by a change in accounting principle.  Pursuant to ASC 250-10-45-17 guidance, this accounting change will not be accounted for as a cumulative effect adjustment on the statement of operations in the period of change and there will be no retroactive application or restatement of prior periods.  Instead, the Company allocates the remaining unamortized balance over the remaining life of the assets using the newly adopted method.

The following compares line items on the statement of operations had the change in amortization methodology not been made:

  

As reported

  

Prior methodology

  

As reported

  

Prior methodology

 
  

3 months ended

  

3 months ended

  

9 months ended

  

9 months ended

 
  

September 30, 2019

  

September 30, 2019

  

September 30, 2019

  

September 30, 2019

 

Amortization of software license rights

 $281,137  $749,887  $843,287  $2,249,537 

Total operating expenses

 $1,215,197  $1,683,947  $4,326,236  $5,732,486 

Operating loss

 $(1,271,136

)

 $(1,739,886

)

 $(4,385,645

)

 $(5,791,895

)

Net loss

 $(1,829,567

)

 $(2,298,317

)

 $(5,058,818

)

 $(6,465,068

)

Basic & diluted loss per share

 $(0.13

)

 $(0.16

)

 $(0.36

)

 $(0.46

)

 

On December 31, 2015, the Company purchased third-party software licenses in the amount of $180,000 in anticipation of a large pending deployment that has yet to materialize. The Company is amortizing the total cost over the same methodology described above with the greatestgreater of the two approaches being the actual unit cost per license sold. A total of $16 and $5,701 and $8,358 was expensedcharged to cost of sales during the three month periods ended September 30, 20192020 and 2018,2019, respectively. A total of $5,044 and $40,394 and $16,460 (netwas charged to cost of credits of $14,400) was expensedsales during the nine-monthnine month periods ended September 30, 20192020 and 2018,2019, respectively. Since the license purchase, the actual per unit cost (actual usage) of such license rights in the cumulative amount of $106,188$111,242 has been charged to cost of sales, with a carrying balance of $73,812$68,758 and $73,802 as of September 30, 2019. The Company has classified the balance as non-current until a larger deployment occurs. Software license rights is comprised of the following as of:2020 and December 31, 2019, respectively.

  

September 30,

  

December 31,

 
  

2019

  

2018

 
         
         

Current resalable software license rights

 $1,125,000  $1,125,000 

Non-current resalable software license rights

  5,906,466   6,790,610 

Total resalable software license rights

 $7,031,466  $7,915,610 

 

 

 

9.11.

investmentsinvestment in debt security

 

During the quarter,2019, the Company purchased a 4,000,000 Hong Kong dollar denominated Bond Certificate with a financial institution in Hong Kong. The Bond Certificate translatestranslated to $512,821 U.S. Dollars.Dollars on the June 2019 purchase date. The bond hashad a one-year maturityterm which matured in June 2020, bearing interest at 5% per annum. The Company redeemed the bond and 5%recorded interest rate.income of approximately $25,800. The Company then purchased a new 4,000,000 Hong Kong dollar denominated Bond Certificate with a financial institution in Hong Kong in June 2020. The new Bond Certificate translated to $516,121 U.S. Dollars, based on the exchange rate at the purchase date. The Company can invest up to a 20,000,000 Hong Kong dollars under the terms of the certificate.  The bond is recorded on the balance sheet as an investment – non-marketable security.certificate, bearing interest at 5% per annum. The investment is recorded at amortized cost which approximates fair value, and is currently planned to be held to maturity.

 

 

 

10.12.

Related Party TRANSACTIONS

 

During the nine months ended September 30, 2019, the  Loans Payable – Related Parties

The Company received a series of non-interest-bearing advances from an executive officer/Mr. Wong Kwok Fong, a director of the Company's principal stockholder, to pay current liabilities. Company, and Mr. Michael DePasquale, the Company’s Chief Executive Officer, for working capital purposes.

The balance of the advanceadvances as at September 30,of December 31, 2019 was paidwere $74,737 and $114,000, respectively, and were due on demand. The advances were repaid in full.full in 2020.

17

 

 

 

11.13.

COMMITMENT

Sales Incentive Agreement with TTI

On March 25, 2020, the Company entered into a sales incentive agreement Technology Transfer Institute (“TTI”). Terms of the agreement include the following:

1.

The term of the agreement is one year unless notice to terminate (as defined) is given. The agreement will be automatically extended for additional one-year terms unless terminated.

2.

For each $5,000,000 in revenue (up to a maximum of $20,000,000) TTI generates during the first year that results in net income of at least 20% (as defined), the Company will pay TTI a sales incentive fee of $500,000 payable by the issuance of 500,000 shares of common stock.

3.

In the event that TTI generates revenue in excess of $20,000,000 during the first year, the Company will issue TTI a five-year warrant to purchase 100,000 shares of Common Stock at an exercise price of $1.50 per share for each $1,000,000 of revenue in excess of $20,000,000 (up to a maximum of $25,000,000).

In no event will the Company be obligated to issue more than 2,000,000 shares of common stock or warrants to purchase more than 500,000 shares of common stock pursuant to this agreement. 

There has been no revenue generated nor sales incentive fees paid during the three and nine months ended September 30, 2020.

14.

Convertible NOTES PAYABLE

 

On April 4,Convertible notes payable as of September 30, 2020 and December 31, 2019 the Company issued a $550,000 secured convertible debenture which had a maturity date of November 15, 2019 and was convertible into common stock at a conversion price of $1.50 per share. The note was redeemable at any time by payment of a premium to the principal balance starting at 5% and increasing to 25%.  The note was issued at approximately 7% ($40,000) original issue discount.  Subject to the mutual agreementconsist of the Company and the investor, the Company could issue two additional $550,000 principal amount notes on the same terms after 45 day intervals from the prior issuance, for additional net proceeds of $1,020,000.  The convertible note contained anti-dilution protections if the Company issued shares of common stock for less than the conversion price. The convertible note was secured by substantially all the assets of the Company.  At the closing, the Company issued 80,000 shares of common stock in payment of a $120,000 commitment fee and was obligated to issue 10,000 shares of common stock monthly in payment of a monthly commitment fee of $15,000 until the earlier of November 1, 2019 or the repayment or conversion of the note.following:

 


  

September 30,

  

December 31,

 
  

2020

  

2019

 
         

Securities Purchase Agreement dated July 10, 2019

 $-  $2,255,454 

January 2020 Note

  -   - 

February 2020 Note

  -   - 

May 2020 Note

  -   - 

June 2020 Note

  -   - 

Convertible notes payable, net

 $-  $2,255,454 

On June 14, 2019, the Company issued a $157,000 secured 10% convertible redeemable note which had a maturity date of November 14, 2019 and was convertible into common stock at a conversion price of $1.50 per share. The convertible redeemable note contained anti-dilution protections if the Company offered a conversion discount or other more favorable conversion terms while the note was outstanding.  The note was redeemable within the first five months by payment of a premium to the principal balance starting at 10% and increasing to 30% of principal plus interest.  At the closing, the Company agreed to issue 200,000 shares of common stock in lieu of payment of a $30,000 commitment fee which would be reduced to 20,000 shares if the note was repaid prior to the maturity date.

Both notes were repaid in full on July 10, 2019.

For the two notes issued during the second quarter of 2019, the Company agreed to issue a total of 310,000 shares of common stock, amounting to $465,000 in commitment fees. Of these amounts, $195,000 was recorded as an offset to notes payable – debt issuance costs and was amortized over the life of the loan.   The reduction of the commitment fee in amount of $270,000 (180,000 shares) was recorded as a reduction in additional paid in capital and the shares were returned to the Company on July 10, 2019. The Company also incurred $17,000 of legal fees withheld from proceeds which was also recorded as an offset to notes payable – debt issuance costs and was amortized over the life of the loan. Amortization of the debt issuance costs and debt discount are included in interest expense on the statement of operations. 

 

Securities Purchase Agreement dated July 10, 2019

 

On July 10, 2019, the Company issued a $3,060,000 principal amount senior secured convertible note (the “Note”“Original Note”). At closing, a total of $2,550,000 was funded. The original issue discount was $510,000. The principal amount due of the Original Note iswas due and payable as follows: $918,000 iswas due 180 days after funding, $1,071,000 iswas due 270 days after funding, and the remaining balance is due 12 months after the date of funding. Upon the occurrence of standard and customary events of default and expiration of any applicable cure periods, repayment of the outstanding principal amount due under the Note is subject to acceleration in the discretion of the Investor in which event, interest will accrue at the higher of 18% per annum or the maximum amount permitted by applicable law and the Company will become obligated to pay an amount equal to 20% of the then outstanding principal amount due under the Note.  

 

The Original Note iswas secured by a lien on substantially all of the Company’s assets and properties and iswas convertible at the option of the Investor intoin shares of common stock at a fixed conversion price of $1.50 per share. The Company has the right to prepay the Note in full at any time without penalty in which event, the Investor will have the option of converting 25% of the outstanding principal amount of the Note into shares of common stock.

 

In connection with the closing of the Original Note, the Company issued a five yearfive-year warrant to the Investor to purchase 2,000,000 shares of common stock at a fixed exercise price of $1.50 per share, paid a $50,000 commitment fee, and issued 266,667 shares of common stock in payment of a $400,000 due diligence fee. The Company also paid banker fees of $193,500 and legal fees of $71,330. The valuation of the warrant of $595,662 was recorded to debt discount and iswas amortized over the life of the Original Note. The fees associated with the agreement were allocated to debt issuance costs and additional paid-in capital based on the respective ratio of the valuation of the note and warrant. Amortization of the debt issuance costs and debt discount are included in interest expense on the statement of operations.

 

On March 12, 2020, the Company issued a $3,789,000 principal amount senior secured convertible note (the “Amended Note”), which replaced the Original Note and included an additional $729,000 in interest due to the debt restructuring. The principal amount was due and payable in full on April 13, 2020. The Amended Note was secured by a lien on substantially all of the Company’s assets and properties and was convertible at the option of the Investor into shares of common stock at a fixed conversion price of $0.65 per share. The Company accounted for the transaction as a debt extinguishment, and therefore, the balance of the fees and unamortized discount associated with the Original Note were written off and included as loss on extinguishment of debt. On the day of the conversion, the closing stock price for the day was $0.76, which resulted in a beneficial conversion of $0.11 per share outstanding or $641,215 to be amortized to interest expense over the term of the Amended Note, as adjusted for any debt conversion.

On April 12, 2020, and May 6, 2020, the Company entered into amendments (the “Amendments”) to the Amended Note. The Amendments extended the maturity date to June 12, 2020 and extended the Investor’s right to convert the Amended Note into shares of the Company’s common stock at a price of $0.65 per share through June 12, 2020. All other provisions of the Amended Note remained the same.

18

Until the second anniversary of the closing, the Investorinvestor has the right to purchase up to 20% of the securities the Company issues in any future private placement, subject to certain exceptions for, among other things, strategic investments.

 

SecuredOn June 10, 2020, the investor converted the last of the remaining principal into shares of common stock for payment in full, and the remaining principal balance was $0. The Amended Note amount of $3,789,000 was converted into 5,829,225 shares of common stock.

  

September 30,

  

December 31,

 
  

2020

  

2019

 

Principal amount

 $3,789,000  $3,060,000 

Less: conversion of principal into shares of common stock

  (3,789,000

)

  - 

Net Principal amount

  -   3,060,000 
         

Less: unamortized debt discount and beneficial conversion feature

  -   (574,330

)

Less: unamortized debt issuance costs

  -   (230,216

)

Notes payable, net of unamortized debt discount and debt issuance costs

 $-  $2,255,454 

January 2020 Note

On January 13, 2020, the Company issued a $157,000 principal amount secured 10% convertible redeemable note (the “January 2020 Note”) to an institutional investor with a maturity date of June 13, 2020 which was convertible into common stock at a conversion price of $1.50 per share. The January 2020 Note was redeemable at any time by payment of a premium to the principal balance starting at 10% and increasing to 30%. At the closing, the Company agreed to issue 650,000 shares of common stock in lieu of payment of a $75,000 commitment fee which would be reduced to 50,000 shares if the January 2020 Note was repaid prior to the maturity date. The Company paid $7,000 of legal fees for the January 2020 Note.

On June 12, 2020, the January 2020 Note was paid in full for $211,984. The 600,000 shares were returned to the Company in July 2020.

February 2020 Note

On February 13, 2020, the Company issued a $126,000 principal amount secured 10% convertible redeemable note (the “February 2020 Note”) to an institutional investor with a maturity date of July 13, 2020 which was convertible into common stock at a conversion price of $1.15 per share.  On March 12, 2020, the Original Note was amended to reduce the conversion price to $0.65 per share, which reduced the conversion price of the February Note to $0.65 and resulted in an additional deemed dividend expense of $70,998. The February 2020 Note was redeemable at any time by payment of a premium to the principal balance starting at 10% and increasing to 30%.   The Company issued 50,000 shares of common stock to the investor in lieu of payment of a $57,500 commitment fee. The Company paid $6,000 of legal fees in connection with the issuance of February 2020 Note.

This February 2020 Note was paid in full on July 10, 2020 by payment of $170,442.

May 2020 Note

On May 6, 2020, the Company issued a $2,415,000 principal amount senior secured convertible note (the “May 2020 Note”). At closing, $2,100,000 was funded. The principal amount was due and payable netin five equal monthly installments of unamortized$268,333 beginning seven months after the funding date with the remaining balance due on the twelfth month after the date of funding. The May 2020 Note was convertible at a fixed convertible price of $1.16 per share. In connection with the issuance of the May 2020 Note, the Company paid a $133,333 due diligence fee by issuing 114,943 shares of common stock to the Investor priced at $1.16 per share. The Company also paid a placement fee of 7% of the gross proceeds to a placement agent. In connection with the closing of the May 2020 Note, the Company issued a five-year warrant to the investor to purchase 1,900,000 shares of common stock at a fixed exercise price of $1.16 and was immediately exercisable. The valuation of the warrant of $876,937 was recorded to debt discount and was amortized over the life of the May 2020 Note. The fees associated with the agreement were allocated to debt issuance costs at September 30, 2019 consisted of:and additional paid-in-capital based on the respective ratio of the valuation of the note and warrant. Amortization of the debt issuance costs and debt discount were included in the interest expense on the statement of operations.

Following the completion of the underwritten offering consummated in July 2020, the principal balance of $2,415,000 was paid in full during the quarter.  As a result of the repayment, the Company expensed the remaining debt discounts and issuance costs of $1,218,163 in July 2020.

 

Principal amount

 $3,060,000 

Less unamortized debt discount

  (856,888

)

Less unamortized debt issuance costs

  (343,477

)

Notes payable, net of unamortized debt discount and debt issuance costs

 $1,859,635 
19

 


June 2020 Note

On June 29, 2020, the Company issued a $1,811,250 principal amount senior secured convertible note (the “June 2020 Note”).  At closing, $1,575,000 was funded. The principal amount was due and payable in nine equal monthly installments of $201,250 beginning four months after the funding date with the remaining balance due on the twelfth month after the date of funding. The June 2020 Note was convertible at a fixed convertible price of $1.16 per share. In connection with the issuance of the June 2020 Note, the Company paid a $100,000 due diligence fee by issuing 136,575 shares to the Investor priced at $0.7322 per share. The Company also paid a placement fee of 7% of the gross proceeds to a placement agent.

In connection with the closing of the June 2020 Note, the Company issued a five-year warrant to the Investor to purchase 1,425,000 shares of common stock at a fixed exercise price of $1.16 per share, and was immediately exercisable. The valuation of the warrant of $511,402 was recorded to debt discount and is being amortized over the life of the June 2020 Note. The fees associated with the agreement were allocated to debt issuance costs and additional paid-in capital based on the respective ratio of the valuation of the note and warrant. Amortization of the debt issuance costs and debt discount are included in interest expense on the statement of operations.

Following the completion of the underwritten offering consummated in July 2020, the principal balance of $1,811,250 was paid in full during the quarter. As a result of the repayment, the Company expensed the remaining debt discounts and issuance costs of $957,919 in July 2020.

 

 

12.15.

LEASES

 

The Company’s leases office space in New Jersey, Hong Kong, Minnesota, and MinnesotaNew Hampshire with lease termination dates of 2023, 2020,2022, 2022, and 2022, respectively. The leases include non-lease components with variable payments. The following tables present the components of lease expense and supplemental balance sheet information related to the operating leases, were:for the three months ended and as of:

 

 

3 Months ended

September 30,

  

9 Months ended September 30,

  

3 Months ended

September 30,

  

9 Months ended

September 30,

 
 

2019

  

2019

  

2020

  

2020

 
                

Lease cost

                

Operating lease cost

 $46,562  $132,524  $67,773  $175,219 

Short-term lease cost

  10,145   41,535 

Sublease income

  -   - 

Total lease cost

 $56,707  $174,059  $67,773  $175,219 
                
Balance sheet information                
Operating ROU assets     $611,883      $556,915 
                
Operating lease liabilities, current portion     $178,130      $229,853 
Operating lease liabilities, non-current portion      426,879       325,454 
Total operating lease liabilities     $605,009      $555,307 
                
Weighted average remaining lease term (in years) – operating leases      3.54       2.49 
Weighted average discount rate – operating leases      5.50%      5.50

%

 

Supplemental cash flow information related to leases were as follows, for the nine months ended September 30, 2019:2020:

 

Cash paid for amounts included in the measurement of operating lease liabilities

 $126,804171,374 

 

Maturities of operating lease liabilities were as follows:

 

2019 (remaining three months)

 $52,301 

2020

  197,724 

2020 (remaining three months)

 $63,812 

2021

  170,853   256,977 

2022

  160,817   187,594 

2023

  89,226   89,226 

Total future lease payments

 $670,921   597,609 

Less: imputed interest

  (65,912

)

  (42,302

)

Total

 $605,009  $555,307 

20

 

 

13.16.

EARNINGS (LOSS) PER SHARE - COMMON STOCK (“EPS”)

 

The Company’s basic EPS is calculated using net loss available to common shareholders and the weighted-average number of shares outstanding during the reporting period. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes and preferred stock.notes.

  

The reconciliation of the numerators of the basic and diluted EPS calculations was as follows for both of the following three and nine month periods ended September 30, 2019 and 2018:

  

Three Months ended

September 30,

  

Nine Months ended

September 30,

 
  

2019

  

2018

  

2019

  

2018

 
                 

Basic and Diluted Numerator:

                

Net loss

 $(1,829,567

)

 $(1,641,315

)

 $(5,058,818

)

 $(5,488,772

)

Deemed dividend from trigger of anti-dilution provision feature

  -   (1,428,966

)

  -   (1,428,966 

Convertible preferred stock dividends

  -   -   -   (198,033

)

Net loss available to common stockholders

 $(1,829,567

)

 $(3,070,281

)

 $(5,058,818

)

 $(7,115,771

)


Items-Items excluded from the diluted per share calculation because the exercise price was greater than the average market price of the common shares:

 

 

Three Months ended

September 30,

  

Nine Months ended

September 30,

  

Three Months ended

September 30,

  

Nine Months ended

September 30,

 
 

2019

  

2018

  

2019

  

2018

  

2020

  

2019

  

2020

  

2019

 
                                

Stock options

  1,755,556   1,541,558   1,755,556   1,335,056   1,603,053   1,755,556   1,603,053   1,755,556 

Warrants

  5,780,978   186,806   5,780,978   186,806   5,651,889   5,780,978   5,651,889   5,780,978 

Convertible notes

  1,912,454   -   1,143,293   - 

Total

  9,448,988   1,728,364   8,679,827   1,521,862   7,254,942   7,536,534   7,254,942   7,536,534 

 

 

The following table summarizes the weighted average securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive due to the net losses for the periods:

 

 

Three Months ended

September 30,

  

Nine Months ended

September 30,

  

Three Months ended

September 30,

  

Nine Months ended

September 30,

 
 

2019

  

2018

  

2019

  

2018

  

2020

  

2019

  

2020

  

2019

 
                                

Preferred stock

  -   -   -   1,902,342 

Stock options

  -   256   -   11,838   2,421   -   18,829   - 

Warrants

  -   785,993   -   992,574   318,600   -   2,945,913   - 
Restricted stock 8,280  -  33,067  - 

Convertible notes

  -   1,912,454   -   1,143,293 

Total

  -   786,249   -   2,906,754   329,301   1,912,454   2,997,809   1,143,293 

 

 

 

14.17.

STOCKHOLDERS’ EQUITY

 

Preferred Stock

 

Within the limits and restrictions provided in the Company’s Certificate of Incorporation, the Board of Directors has the authority, without further action by the shareholders, to issue up to 5,000,000 shares of preferred stock, $.0001 par value per share, in one or more series, and to fix, as to any such series, any dividend rate, redemption price, preference on liquidation or dissolution, sinking fund terms, conversion rights, voting rights, and any other preference or special rights and qualifications. As of September 30, 2019,2020, 100,000 shares of preferred stock have been designated as Series A-1 Convertible Preferred Stock ("Series A-1 Stock"), of which 90,000 were issued in 2015 and 0 remain outstanding, and 105,000 shares of preferred stock have been designated as Series B-1 Convertible Preferred Stock ("Series B-1 Stock"), of which 105,000 were issued in 2015 and 0 remain outstanding.

Series A-1 Convertible Preferred Stock

On October 22 and 29, 2015, the Company issued 84,500 shares of Series A-1 Stock at a purchase price of $100.00 per share, for aggregate gross proceeds of $8,450,000. On November 11, 2015, 5,500 additional shares of Series A-1 Stock were issued at a purchase price of $100.00 per share, for gross cash proceeds of $550,000.

Between September 22, 2017 and May 31, 2018, the holder of the Series A-1 Stock converted all shares of Series A-1 Stock into an aggregate of 2,500,000 shares of commonStock. There was no preferred stock and purchased an aggregate of 248,893 shares of common stock in consideration of the conversion of $896,015 of accrued dividends payable on the Series A-1 Stock.

As a result of the forgoing conversions,outstanding as of September 30, 2019 there are no longer any issued and outstanding shares of Series A-1 Stock.

Overall balances and conversion of Series A-1 Stock and accrued dividends into common stock has been as follows:2020 or December 31, 2019.

 

  

Series A-1

  

Accrued

Dividends

 
         

Balance – January 1, 2017

  90,000  $270,000 

Accrual of dividends – Q1 2017

  -   135,000 

Accrual of dividends – Q2 2017

  -   135,000 

Accrual of dividends – Q3 2017

  -   135,000 

Conversion into common stock – September 2017

  -   (540,000

)

Conversion into common stock – October 2017

  (27,404

)

  - 

Accrual of dividends – Q4 2017

  -   101,658 

Balance – December 31, 2017

  62,596  $236,658 

Accrual of dividends – Q1 2018

  -   93,894 

Conversion into common stock – April 2018

  (39,088

)

  (330,552

)

Accrual of dividends – Q2 2018 (until final conversion)

  -   25,463 

Conversion into common stock – May 2018

  (23,508

)

  (25,463

)

Balance – December 31, 2018

  -  $- 
21

 


Series B-1 Convertible Preferred StockWarrants

 

On November 11, 2015, the Company issued 105,000 shares of Series B-1 Stock at a purchase price of $100.00 per share, for gross proceeds of $10,500,000.  

Between March 23, 2018 and May 23, 2018, holders of shares of Series B-1 Stock converted all shares of Series B-1 Stock into an aggregate of 2,916,668 shares of common stock and purchased an aggregate of 131,229 shares of common stock in consideration of the conversion of $472,426 of accrued dividends payable on the Series B-1 Stock.

As a result of the forgoing conversions, as of September 30, 2019 there are no longer any issued and outstanding shares of Series B-1 Stock.

Overall balances and conversion of Series B-1 Stock and accrued dividends into common stock has been as follows:

  

Series B-1

  

Accrued

Dividends

 
         

Balance – January 1, 2017

  105,000  $131,250 

Accrual of dividends – Q1 2017

  -   65,625 

Accrual of dividends – Q2 2017

  -   65,625 

Accrual of dividends – Q3 2017

  -   65,625 

Accrual of dividends – Q4 2017

  -   65,625 

Balance – December 31, 2017

  105,000   393,750 

Conversion into common stock – March 2018

  (60,420

)

  (417,084

)

Accrual of dividends – Q1 2018

  -   62,268 

Accrual of dividends – Q2 2018 (until final conversion)

  -   16,408 

Conversion into common stock – May 2018

  (44,580

)

  (55,342

)

Balance – December 31, 2018

  -  $- 

Common Stock

On March 21 and 28, 2019, the Company issued 13,820 shares of common stock to its directors in payment of board and board committee fees valued at $16,506. 

On May 14, 2019, the Company issued 4,235 shares of common stock to its directors in payment of board and board committee fees, valued at $5,505.

On August 8 and 14, 2019, the Company issued 6,111 shares of common stock to its directors in payment of board and board committee fees valued at $6,501. 

See Note 11 for common stock issued as commitment fees for notes payable in for the three and nine months ending September 30, 2019. 

Securities Purchase Agreement dated November 13, 20142014:

 

Pursuant toAs part of a Securities Purchase Agreement, dated November 13, 2014, by and between the Company and a number of private and institutional investors, the Company issued to certain private investors 664,584warrants to purchase 996,877 shares of common stock.  The warrants expired in November 2019.

Securities Purchase Agreement dated September 23, 2015:

On September 23, 2015, the Company issued warrants (the “2015 Warrants”) to purchase 69,445 shares of common stock and warrants to purchase an additional 996,877 sharesin connection with the issuance of common stock for aggregate gross proceeds of $1,595,000.

a promissory note. The warrants have a term of five years andwere immediately exercisable at an initial exercise price of $3.60 per share and have been fully exercisable since February 2015.had a term of five years. The warrants have customary anti-dilution protections including2015 Warrants expired in September 2020.

The 2015 Warrants had a “full ratchet”"full ratchet" anti-dilution adjustment provision which arecould be triggered in the event the Company sellssold or grantsgranted any additional shares of common stock, options, warrants or other securities that arewere convertible into common stock at a price lower than $3.60 per share,share. The anti-dilution adjustment provision iswas not triggered by certain “exempt issuances” which among other issuances, includes the issuance of shares of common stock, options or other securities to officers, employees, directors, consultants or service providers.

 

On August 24, 2018 the Company issued Common Stock and Warrants to investors at a purchase price of $1.50 per unit whichAnti-dilution adjustments were triggered the anti-dilution protection provision under this Securities Purchase Agreement. As a result, the total number of outstanding and fully vested warrants was increased from 996,877 to 2,392,502, and the exercise price was reduced from $3.60 to $1.50 per share. The Company recognized a non-cash deemed dividend of $1,288,139 in 2018 in connection with these adjustments.as follows:

 


1.

On August 24, 2018 the Company issued warrants to certain investors which triggered the anti-dilution provisions included in the 2015 Warrants. As a result, the number of shares of common stock issuable upon the full exercise of the 2015 Warrants was increased from 69,445 to 166,668 shares, and the exercise price was reduced from $3.60 to $1.50 per share.

2.

On February 14, 2020, the February 2020 Note was issued at a conversion price of $1.15 that triggered the anti-dilution provisions included in these warrants. In addition, the amendments to the Original Note reduced the conversion price of the Original Note to $0.65 which also triggered the anti-dilution provision of the 2015 Warrants. As a result of the forgoing transactions, the number of shares of common stock issuable upon the full exercise of the 2015 Warrants increased to 384,618, the exercise was reduced to $0.65 per share, and the Company recorded a non-cash deemed dividend in amount of $41,688.

 

Securities Purchase Agreement dated September 23, 2015Referral Fees:

 

On September 23, 2015,During the second quarter of 2020, the Company issued a warrant to purchase 69,445125,000 shares of common stock to an investor in connection with the issuance ofpayment for a promissory note. The warrants are immediately exercisablebusiness referral valued at an initial exercise price of $3.60 per share and have a term of five years. $94,655.

 

The warrants have customary anti-dilution protections including a "full ratchet" anti-dilution adjustment provision which are triggered inDuring the eventthird quarter of 2020, the Company sells orgrants any additionalissued a warrant to purchase 25,000 shares of common stock options, warrants or other securities that are convertible intoto a former employee for a business referral valued at $12,921.

Common Stock

On March 30, 2020, the Company issued 972,000 shares of common stock for warrants that were exercised at a price lower than $3.60 per share. The anti-dilution adjustment provision is not triggered by certain "exempt issuances" which among other issuances, includes$1.50, resulting in proceeds of $1,458,000 to the issuanceCompany.

On April 2, 2020, the Company issued 6,850 shares of common stock to its directors in payment of meeting fees valued at $5,001.

On May 12, 2020, the Company issued 7,077 shares of common stock to its directors in payment of meeting fees valued at $7,003. 

On May 14, 2020, the Company issued 1,632 shares of common stock to its directors in payment of committee meeting fees valued at $1,501.

On June 8, 2020, the Company issued 1,581 shares of common stock to its directors in payment of committee meeting fees valued at $1,502.

22

On July 23, 2020, the Company completed an underwritten public offering of shares of common stock options or other securities to officers, employees, directors, consultants or service providers.and warrants resulting in net proceeds of approximately $22.7 million, after deducting underwriting discounts and commissions and estimated offering expenses. 34,114,500 shares of common stock were issued as a result of this offering, and a further 6,364,300 shares of common stock were issued upon the exercise of 4,100,000 prefunded warrants and 2,264,300 warrants exercised in conjunction with the offering.

 

On August 24, 201810,328 shares of common stock were issued during the Companyquarter ended September 30, 2020 in payment of board and board committee fees valued at $7,003. 

See Note 14 - Convertible Notes Payable for common stock issuances related to conversion of convertible notes payable and shares of common stock issued Common Stock and Warrants to the investors at a purchase price of $1.50 per unit which triggered the anti-dilution protection provision under this Securities Purchase Agreement. As a result, the total number of outstanding and fully vested warrants was increased from 69,445 to 166,668, and the exercise price was reduced from $3.60 to $1.50 per share. The Company recognized a non-cash deemed dividend of $140,827 in 2018for fees in connection with these adjustments.the agreements.

Issuances of Nonvested Stock

Nonvested stock consists of shares of common stock that are subject to restrictions on transfer and risk of forfeiture until the fulfillment of specified conditions. The fair value of nonvested shares is determined based on the market price of the Company's common stock on the grant date. Nonvested stock is expensed ratably over the term of the restriction period.

The Company issued 306,000 shares of restricted common stock during the quarter ended September 30, 2020 to certain employees and directors of the Company. These shares vest in equal annual installments over a three-year period from the date of grant, and had a fair value on the date of issuance of $198,900. Nonvested stock compensation for the three months ended September 30, 2020 was $3,427.

 

 

Issuances of Stock Options

 

4,000On April 2, 2020, the Company issued a stock option to a new employee to purchase 5,000 shares of common stock with a three-year vesting period, seven year term, and exercise price of $0.73 per share. 

The fair value of the option at date of issuance was estimated on the date of grant at $2,267 using the Black-Scholes option-pricing model with the following assumptions: risk free interest rate: 0.36%, expected life of options in years: 4.5, expected dividends: 0, volatility of stock price: 83%.

197,500 options were granted during the quarter ended September 30, 2019.  The2020. These options have avest in three year vestingequal annual installments on each of the three anniversaries of the date of grant period, have seven year term,terms, and a weighted average exercise price of $1.13.$0.65. The fair value of the options at date of issuance was estimated on the date of grant at $3,956$80,093 using the Black-Scholes option-pricing model with the following assumptions: risk free interest rate: 1.55%0.28%, expected life of options in years: 4.5,4.53, expected dividends: 0, volatility of stock price: 83%.

23

18.

NASDAQ CAPITAL MARKET LISTING REQUIREMENTS

In September 2019, the Company received a letter from Nasdaq stating that its share price had not satisfied the continued listing requirement to maintain a minimum bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2). On November 16, 2020, the Company held a special meeting of its stockholders to request a vote in favor of a reverse split at a ratio between 1-for-4 and 1-for-10, to regain compliance with the Minimum Bid Price Requirement. We have until December 4, 2020 to regain compliance with the Minimum Bid Price Requirement. 

On May 18, 2020 the Company received a notice (the “Notice”) from the Staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Capital Market LLC (“Nasdaq”) indicating the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1) because, the Company did not have a minimum of $2,500,000 in stockholders’ equity for continued listing on Nasdaq (the “Stockholders’ Equity Requirement”). On July 10, 2020, the Company’s  plan to regain compliance with the Stockholders’ Equity Requirement previously submitted to the Nasdaq was accepted and Nasdaq granted us an extension of 180 calendar days from the date of the Notice (November 16, 2020) for to provide evidence of compliance. 

As discussed above, on July 23, 2020, the Company completed an underwritten public offering resulting in net cash proceeds of approximately $22.7 million which was used, in part, to repay approximately $4.2 million of outstanding convertible promissory notes. Accordingly, as of the date of this report the Company believes that it has satisfied compliance with the Stockholders’ Equity Requirement.

 

 

 

15.19.

SEGMENT INFORMATION

 

The Company has determined that its continuing operations are one discrete segment consisting of biometric products. Geographically, North American sales accounted for approximately 79%95% and 59%79% of the Company’s total sales for the three months ended September 30, 20192020 and 2018,2019, respectively, and were approximately 56%90% and 56% of the Company’s total sales for the nine months ended September 30, 20192020 and 2018,2019, respectively. 

 

  

 

16.20.

FAIR VALUES OF FINANCIAL INSTRUMENTS

 

Cash and cash equivalents, accounts receivable, accounts payable, accrued liabilities, note payable, and due from factor, are carried at, or approximate, fair value because of their short-term nature.  The carrying values of the convertible debt and operating lease obligation approximated their fair values as the interest rates approximated market.

 

 

 

17.21.

MAJOR CUSTOMERS AND ACCOUNTS RECEIVABLE

 

For the three months ended September 30, 20192020 and 2018,2019, one customer accounted for 28%13% and three customersone customer accounted for 56%28% of revenue, respectively. For the nine months ended September 30, 2020 and 2019, one customer accounted for 21% and 2018, three customers accounted for 50% and two customers accounted for 39% of revenue, respectively.

 

At September 30, 2019, one customer2020, two customers accounted for 71%26% of accounts receivable. At December 31, 2018, one customer2019, three customers accounted for 70%18%, 16% and 14% of current accounts receivable. One customer accounted for 100% of non-current accounts receivable, as of September 30, 2019 and December 31, 2018, the full amount of which has been reserved for.respectively.

 

 

 

 

18.22.

PAYMENT PROTECTION PROGRAM TERM NOTE

On April 20, 2020, the Company entered into a Paycheck Protection Program Term Note (the “SVB Note”) with Silicon Valley Bank (“SVB”) pursuant to the Paycheck Protection Program (the “Program”) of the recently enacted Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) administered by the U.S. Small Business Administration.

The Company received total proceeds of approximately $341,000 which were used in accordance with the requirements of the CARES Act.  The Company will apply to SVB for forgiveness of amounts due on the SVB Note to the extent they are used for eligible payroll costs, rent obligations, and covered utility payments incurred during the “covered period” following disbursement under the SVB Note.  Until the six-month anniversary of the date of the SVB Note (the “Deferral Expiration Date”), neither principal nor interest is due and payable. On the Deferral Expiration Date, the outstanding principal of the SVB Note that is not forgiven will convert to an amortizing term loan at an interest rate of 1% per annum requiring equal monthly payments of principal and interest through November 20, 2022.

The Company has performed initial calculations for the SVB Note forgiveness according to the terms and conditions of the SBA’s  Loan Forgiveness Application (Revised June 16, 2020) and, based on such calculations, expects that the SVB Note will be forgiven in full. In addition, the Company has determined that it is probable the Company will meet all the conditions of the SVB Note forgiveness. As such, the Company has decided that the SVB Note should be accounted for as a government grant which analogizes with International Accounting Standards (“IAS”) 20, Accounting for Government Grants and Disclosure of Government Assistance. Under the provisions of IAS 20, “a forgivable loan from government is treated as a government grant when there is reasonable assurance that the entity will meet the terms for forgiveness of the loan.” IAS 20 does not define “reasonable assurance”, however, based on certain interpretations, it is analogous to “probable” in U.S. GAAP under FASB ASC 450-20-20, which is the definition the Company has applied to its expectations of the SVB Note forgiveness. In addition, in accordance with the provisions of IAS 20, government grants shall be recognized in profit or loss on a systematic basis over the periods in which the Company recognizes costs for which the grant is intended to compensate (i.e. qualified expenses). Therefore, the Company recognized the funding during the periods when qualified expenses were incurred. 

23.

SUBSEQUENT EVENTS

 

On November 12, 2019,11, 2020, the Company issued 9,84511,115 shares of common stock to its directors in payment of board fees. Additionally, the Company issued a stock option to a new employee to purchase 25,000 shares of common stock with three-year vesting period and seven year term, and an aggregate of 25,000 shares of restricted common stock  to several new employees which vest in equal annual installments over a three year period from the date of grant.

  

The Company has reviewed all other subsequent events through the date of filing. 

 


24

 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS

 

CAUTIONARY STATEMENT FOR FORWARD-LOOKING STATEMENTS

 

All statements other than statements of historical facts contained in this Report on Form 10-Q, including statements regarding our future financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “will,” “may,” “future,” “plan,” “intend” and “expect” and similar expressions generally identify forward-looking statements. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Although we believe that our plans, intentions and expectations reflected in the forward-looking statements are reasonable, we cannot be sure that they will be achieved. Particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include: our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition between us and other companies in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to execute and deliver on contracts in Africa, our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the Asian market;operations and personnel of PistolStar into our business; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 20182019 filed with the Securities and Exchange Commission.Commission (the “SEC”) and other filing with the SEC. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. Except as required by law, we undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

OVERVIEW

 

The following discussion and analysis summarizes the significant factors affecting the operating results, financial condition, liquidity and cash flows of our Company as of and for the periods presented below and should be read in conjunction with our unaudited condensed consolidated financial statements and related information contained herein and in our audited financial statements as of December 31, 2018.2019.

OVERVIEW

 

BIO-key International, Inc. (the “Company”Company, “we”we or “us”us) develops and markets advanced fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing fingerprint biometric hardware and software solutions. We were pioneers in developing automated, finger identification technology that supplements or compliments other methods of identification and verification, such as personal inspection identification, passwords, tokens, keys, smart cards, ID cards, PKI, credit card, passports, driver’s licenses, OTP or other formforms of possession or knowledge-based credentialing. Advanced BIO-keyBIO-key® technology has been and is used to improve both the accuracy and speed of competing finger-based biometrics. Our solutions are used by many customers in every sector of our economy including government, financial services, education, manufacturing, retail, healthcare and financial services.call centers.

 

In partnerships with OEMs, integrators, and solution providers, we provide biometric software solutions to private and public sector customers.  We provide the ability to positively identify and authenticate individuals before granting access to valuable corporate resources, web portals or applications in seconds. Powered by our patented Vector Segment Technology (VST™), or VST, WEB-keyWEB-key® and BSP development kits are fingerprint biometric solutions that provide interoperability with all majordozens of reader manufacturers, enabling application developers and integrators to integrate fingerprint biometrics into their applications.

Our biometric identification technology improves both the accuracy and speed of screening individuals, for identification purposes or for personal identity verification, by extracting unique data from a fingerprint and comparing it to existing similar fingerprint data. The technology has been built to be scalable and to handle databases containing millions of fingerprints. We achieve the highest levels of discrimination without requiring any other identifying data (multi-factor) such as a user ID, smart cards, or tokens, although our technology can be used in conjunction with such additional factors. Users of our technology have the option of on device or cloud authentication. This flexible authentication option in conjunction with our interoperable capabilities, is another key differentiator of our biometric identification solutions.

Our WEB-key solution is a client server suite that can be integrated into virtually any application, whether web based or desktop application based on Windows. The WEB-key solution is a security solution that protects the biometric data in processing, transmission and storage. WEB-key provides a turn-key solution for biometric as well as multi-factor authentication across an enterprise, government system or any user population.

25

 

We also develop and distribute hardware components that are used in conjunction with our software, and sell third-party hardware components with our software in various configurations required by our customers. Our products are interoperable with all major fingerprint reader and hardware manufacturers, and acrosssupporting Windows, Linux, Mac OS X, and the Android mobile operating systems enabling application developers, value added resellers, and channel partners to integrate our fingerprint biometrics into their applications, while dramatically reducing maintenance, upgrade and life-cycle costs. This interoperability is unique in the industry, and a key differentiator for our products in the biometric market. In our opinion, these features make our technology more viable than competing technologies and expands the size of the overall market for our products.

In partnerships with OEMs, VARs, integrators, and solution providers, we market and sell biometric hardware and software solutions to SMBs, the Fortune 500 and government agencies.

 

We support industry standards, such as FIDO,including PIV, FIPS, ANSI, ISO, SAML, and BioAPI andamong others. We have received National Institute of Standards and Technology (NIST) independent laboratory testing and certification of our ability to support Homeland Security Presidential Directive #12 (HSPD-12) and ANSI/INCITS-378 templates, as well as validation of our fingerprint match speed and accuracy in large database environments.

 

We have developed what we believe is the most discriminating and effective commercially available finger-based biometric technology. Our primary focus is in marketing and selling this technology into commercial logicalto customers seeking to secure access to networks, applications and physical privilege entitlement & access control markets.data on-premises or remotely. Our primary market focus includes, among others, enterprise access, mobile payments & credentialing, online payments, and healthcare record and payment data security.  Our secondary focus includes government, financial services, education, healthcare, manufacturing, retail, and educational markets.call centers.  


 

Products

 

In 2016, we beganWe also offer a full line of easy to selluse finger scanners for both enterprise and consumer markets. Our SideSwipe®, SideTouch® and EcoID® scanners are plug and play compatible with Microsoft Windows and our Q-180 Touch reader is a Micro USB compatible fingerprint reader for Android devices. The readers are currently sold in the Microsoft stores, as well as through distributiontheir on-line channel, on Amazon, and directly to consumers and commercial usersthrough our SideSwipe, SideTouch and EcoID products. SideSwipe, SideTouch and EcoID are stand-alone fingerprint readers that can be used on any laptop, tablet or other device with a USB port. In 2017, we expanded our consumer product line to include biometric and blue tooth enabled pad locks, TSA approved luggage locks, and bicycle locks.website. In 2018, we introduced OmniPass Consumer, a secure biometric-enabled application to manage multiple passwords for online apps, services, or accounts.

 

In 2015, Microsoft announced native support for biometrics in the Windows 8.1 and Windows 10 Operating platforms as well as Office 2016. With Microsoft Hello, any user can replace their PIN or password to access their device without any special software downloads by using our finger scanners, SideSwipe, SideTouch and EcoID, which are plug and play compatible with the Microsoft platforms. We have been the preferred partner, in particular at the Microsoft “Ignite your Business” Windows 10 and Office 2016 launch events, which has generated a number opportunities for both our hardware and software offerings. In 2016, our finger scanners were tested and qualified by Microsoft, then introduced and are sold in the Microsoft stores nationwide, as well as through their on-line channel. events.

 

In 2019, we continuedFinally, our ID Director for Windows and ID Director for SAML offer biometric authentication to investSAML enables apps such as Office 365, GoToMeeting, Zoom, SalesForce, Google G-Suite, and grow our relationship with Microsoft including and attending the 2019 Ignite your Business event in November 2019.many others.

 

STRATEGIC OUTLOOK AND RECENT DEVELOPMENTS

 

Historically, our largest market has been access control within highly regulated industries such as government, financial services, and healthcare.  However,During 2019, we believebecame the mass adoptiongo-to biometric authentication provider for board of advanced smart-phoneelection offices as eight offices deployed our hardware and hand-held wireless devices have caused commercial demand for advanced usersoftware to secure internal access to the voter registration database. We continue to seek to extend this footprint as we finalize 2020 and move forward into 2021.

Working with our partner TTI, we expect to begin deploying several large-scale identity and access projects in the fourth quarter of 2020. We are in the process of establishing an African subsidiary, to work closely with TTI who was awarded contracts of $45M and $30M. Under the first contract, we will provide biometric authentication to emerge as viable.support the infrastructure of a new e-commerce project developed with the expectation to generate more than one million jobs in Nigeria. The introductionsecond contract provides for BIO-key hardware and software to be used by a leading African telecommunications company to secure internal access to customer data. Based on information available today, Africa and the surrounding regions are receiving government funding to expand the use of smart-phone capabilities, like mobile paymentsbiometric authentication solutions to help establish trustworthy government programs and credentialing, could effectively require biometric user authentication on mobile devicesreduce fraud. The COVID-19 pandemic has and may continue to reduce risksdelay the rollout of identity theft, payment fraud and other forms of fraudthese programs, but we are expecting to begin deploying hardware Q4 2020 in accordance with contractual terms.

We plan to have a more significant role in the mobile or cellular based world wide web. AsIdentity and Access Management (IAM) market which continues to expand. We plan to offer customers a suite of authentication options that complement our biometric solutions. The more services and payment functionalities, such as mobile wallets and near field communication (NFC), migratewell-rounded offerings of authentication options will allow customers to smart-phones, the value and potential risk associated with such systems should grow and drive demand and adoption of advanced usercustomize their approach to authentication technologies, including fingerprint biometrics and BIO-key solutions.   all under one umbrella.

26

 

As devices with onboard fingerprint sensors continue to deploy to consumers, we expect that third partythird-party application developers will demand the ability to authenticate users of their respective applications (app’s)(apps) with the onboard fingerprint biometric. We further believe that authentication will occur on the device itself for potentially low-value, and therefore low-risk, use-transactions and that user authentication for high-value transactions will migrate to the application provider’s authentication server, typically located within their supporting technology infrastructure, or Cloud.cloud. We have developed our technology to enable, on-device authentication as well as network or cloud-based authentication and believe we may be the only technology vendor capable of providing this flexibility and capability.

Our core technology works on over 40major commercially available fingerprint readers, across both Windows and Linux, platforms,Mac OS X and Apple iOS and Android mobile operating systems. This interoperability, coupled with the ability to authenticauthenticate users via the device or cloud, is unique in the industry, provides a key differentiator for us, and in our opinion, makes our technology more viable than competing technologies and expands the size of the overall market for our products.

In June 2020, we expanded our business though the acquisition of PistolStar. PistolStar has over 200 active customer subscribers which include PortalGuard® multi-factor authentication (MFA), Nebula identity-as-a-service (IDaaS), PortalGuard single sign-on (SSO) and PortalGuard self-service password reset (SSPR).

PortalGuard MFA offers customers flexible policy-driven choices among 15 different methods of authentication, including BIO-key biometrics, FIDO U2F/2FA tokens, WebAuthn, Windows Hello, Google Authenticator, Microsoft Authenticator, RSA SecureID, Phone Push, OTP, SMS, phone-call, and bar-code, so every user can always be securely authenticated with whichever factor is most appropriate.  For enterprises with existing IAM platforms, PortalGuard can be seamlessly integrated to add its complete MFA by supporting SAML, OpenID Connect, OAuth, WS-Federation, CAS, and Shibboleth, among other standards. Combining PistolStar’s proprietary authentication software with our biometric solutions creates an integrated turn-key multi-factor solution which we believe is unparalleled in the industry, and will allow us to provide a unified MFA solution that is differentiated in the market by our biometric user experience and who-you-are strong authentication.

 

We believe there is potential for significant market growth in the following key areas:

 

Corporate network access control, corporate campuses, computer networks, and applications.

Large scale identification projects, especially in Africa and the surrounding regions.

Government funded initiatives, including with the state board of elections.

International governmentlaw enforcement use case applications as prospects see us as a global leader in the biometric technology based onspace as witnessed by our agreementsagreement with the Israeli Defense Force, and the Singapore and Dubai Police departments.

Consumer mobile credentialing, including mobile payments, credit and payment card programs, data and application access, and commercial loyalty programs.

Demand for BIO-key hardware products from Windows 10 users and Fortune 500 companies.

Government services and highly regulated industries including, Medicare, Medicaid, Social Security, Drivers Licenses, Campus and School ID, Passports/Visas.

GrowthContinued growth in the Asia Pacific region.


New remote authentication challenges – which our solutions are ideally suited to address.

New opportunity to market remote security solutions which have been accelerated due to the COVID-19 pandemic.

 

In the near-term, we expect to grow our business within government services and highly-regulated industries such as healthcare and financial services industry.in which we have historically had a strong presence.  We believe that continued heightened security and privacy requirements in these industries will generate increased demand for security solutions, including biometrics. In addition, we expect that the integration of our technology into Windows 10, will accelerate the demand for our computer network log-on solutions and fingerprint readers. Finally, our entry

Our two primary sales strategies call for expanded marketing efforts into the AsianIAM market has further expanded our business by opening new markets along with a dedicated pursuit of large-scale identification projects across the new and innovative hardware offerings. We expect our SideSwipe, EcoID and SideTouch finger readers to continue to drive incremental revenue and growth. globe.

 

We also plan on expanding our new Channel Alliance Program which now has more than twenty participants and started to generate modest initial revenues.

Impact of COVID-19

In March 2020, the World Health Organization declared the outbreak of COVID-19 as a global pandemic, and, in the following weeks, many U.S. states and localities issued lockdown orders impacting our operations. Since then, the COVID-19 situation within the U.S. has rapidly escalated and has severely restricted the level of economic activity around the world. The COVID-19 outbreak has caused us to migrate to a remote business model for our sales, marketing, administrative and executive teams. Research and development and production are adjusting to the new landscape to maintain production as best as possible considering the conditions and regulations. We continue to monitor the situation closely and it is possible that we will implement further measures. Since we qualify as an essential business in New Jersey because we serve the healthcare industry, we have expanded ourbeen able to access inventory to fulfill orders and ship products as required. The pandemic has extended sales cycles and delayed deployments in most markets in which we operate, particularly in Africa which has just recently lifted shut-down and shelter at home orders. We continue to conduct business intodaily and are actively closing transactions throughout the cloudcurrent climate, with no changes to personnel.

27

The complications caused by the pandemic have forced organizations to quickly adapt to a work from home remote business model. This increases the risk of unauthorized users, phishing attacks, and mobile computing industries. The emergencehackers eager to take advantage of cloud computing and mobile computing are primary driversthe challenges of commercial and consumer adoption of advanced authentication applications, including biometric and BIO-key authentication capabilities.  As the value of assets, services and transactions increases on such networks, we expectsecuring remote workers. We believe that security andbiometrics should play a key role in remote user authentication demand should rise proportionately. Our integration partners include major web and network technology providers, who we believe will deliver our cloud-applicable solutions to interested service-providers. These service-providers could include, but are not limited to, financial institutions, web-service providers, consumer payment service providers, credit reporting services, consumer data service providers, healthcare providers and others. Additionally, our integration partners include major technology component providers and OEM manufacturers, who we believe will deliver our device-applicable solutions to interested hardware manufacturers. Such manufacturers could include cellular handset and smartphone manufacturers, tablet manufacturers, laptop and PC manufacturers, among other hardware manufacturers. Our recently introduced SAML and Open ID solutions will create new opportunities for us going forward.authentication.

 

 

CRITICAL ACCOUNTING POLICIES

 

For detailed information regarding our critical accounting policies and estimates, see our financial statements and notes thereto included in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2018.2019.  There have been no material changes to our critical accounting policies and estimates from those disclosed in our most recent Annual Report on Form 10-K, except for adoption of Leases (ASC 842) – refer Note 1.10-K.

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

For detailed information regarding recent account pronouncements, see Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this report.

 

RESULTS OF OPERATIONS

 

THREE MONTHS ENDED SEPTEMBER 30, 20192020 AS COMPARED TO SEPTEMBER 30, 20182019

 

Consolidated Results of Operations - Percent Trend

 

 

% of Total Revenues for the

Three Months Ended

September 30,

  

% of Total Revenues for the

Three Months Ended

September 30,

 
 

2019

  

2018

  

2020

  

2019

 

Revenues

                

Services

  52

%

  31

%

  52

%

  52

%

License fees

  22

%

  28

%

  37

%

  22

%

Hardware

  26

%

  41

%

  11

%

  26

%

Total revenues

  100

%

  100

%

  100

%

  100

%

Costs and other expenses

                

Cost of services

  15

%

  13

%

  18

%

  15

%

Cost of license fees

  82

%

  102

%

  1

%

  82

%

Cost of hardware

  16

%

  12

%

  3

%

  16

%

Total costs and other expenses

  112

%

  127

%

  22

%

  112

%

Gross Profit

  -12

%

  -27

%

Gross Profit (loss)

  78

%

  -12

%

                

Operating expenses

                

Selling, general and administrative

  202

%

  142

%

  158

%

  202

%

Research, development and engineering

  66

%

  53

%

  35

%

  66

%

Total operating expenses

  268

%

  195

%

  193

%

  268

%

Operating loss

  -281

%

  -222

%

  -116

%

  -281

%

                

Other income (expense)

        

Other income (expense)

        

Total other income (expense)

  -123

%

  -

%

  -234

%

  -123

%

Net loss

  -404

%

  -222

%

  -349

%

  -404

%

 


28

 

Revenues and cost of goods sold

 

 

Three months ended

September 30,

          

Three months ended

September 30,

         
 

2019

  

2018

  

$ Change

  

% Change

  

2020

  

2019

  

$ Change

  

% Change

 
                                

Revenues

                                

Service

 $237,372  $225,739  $11,633   5

%

 $491,535  $237,372  $254,163   107

%

License

  98,272   210,651   (112,379

)

  -53

%

  346,479   98,272   248,207   253

%

Hardware

  117,070   303,360   (186,290

)

  -61

%

  105,311   117,070   (11,759

)

  -10

%

Total Revenue

 $452,714  $739,750  $(287,036

)

  -39

%

 $943,325  $452,714  $490,611   108

%

                                

Cost of goods sold

                                

Service

 $65,683  $97,965  $(32,282

)

  -33

%

 $173,823  $65,683  $108,140   165

%

License

  369,604   757,288   (387,684

)

  -51

%

  10,775   369,604   (358,829

)

  -97

%

Hardware

  73,366   85,079   (11,713

)

  -14

%

  27,011   73,366   (46,355

)

  -63

%

Total COGS

 $508,653  $940,332  $(431,679

)

  -46

%

 $211,609  $508,653  $(297,044

)

  -58

%

  

Revenues

 

For the three months ended September 30, 20192020 and 2018,2019, service revenues included approximately $224,000$480,000 and $220,000,$224,000, respectively, of recurring maintenance and support revenue, and approximately $13,000$11,000 and $6,000$13,000 respectively, of non-recurring custom services revenue.  Recurring service revenue increased 2%114% in 2019 as we expanded our customer license base, and renewed existing maintenance agreements with our legacy2020 which is largely due to the additional PistolStar service revenue customers. Non-recurring custom services increased 117%decreased 15% for custom services due to increaseddecreased customers paying for installations. We expect the recurring revenue for PistolStar to decrease, and license revenue to increase, as we continue to convert Portal Guard offerings to a subscription model.

 

For the three months ended September 30, 2019,2020, license revenue decreased 53%increased 253% from the corresponding period in 20182019 due to the absencenew customer orders from PistolStar, and the new customer orders of large orders, while we increased the diversity and number of customers by executing additional smaller orders.PortalGuard.

 

For the three months ended September 30, 2019,2020, hardware sales decreased by approximately $186,000 (61%$12,000 (10%), as a result of smaller new customer deployments and a decreased volume of lock orders.no orders for locks. 

  

Costs of goods sold

��

For the three months ended September 30, 2019,2020, cost of service decreased 33%,increased 165% over the corresponding period in 2019, due to reducedaddition of the PistolStar costs associated with support required for existing custom services revenue.

 

License costs for the three months ended September 30, 20192020 decreased approximately 51%97%, and were directly associated with the amortization of the software rights, in addition to lower revenue.which were written off by December 31, 2019.

 

Hardware costs for the three months ended September 30, 20192020 decreased approximately 14%63%. The decrease was associated with the reduced hardware sales and hardware mix.

 

Selling, general and administrative

 

  

Three months ended

September 30,

         
  

2019

  

2018

  

$ Change

  

% Change

 
                 

Selling, general and administrative

 $915,066  $1,049,270  $(134,204

)

  -13

%

  

Three months ended

September 30,

        
  

2020

  

2019

  

$ Change

  

% Change

 
                 

Selling, general and administrative

 $1,490,241  $915,066  $575,175   63

%

 

Selling, general and administrative costs for the three months ended September 30, 2019 decreased 13%2020 increased 63% from the corresponding period in 2018.2019. The net decreaseincrease included decreasesexpenses associated with new marketing personnel and web-site integration of PistolStar, additional costs associated with the PistolStar office staff and expenses, one-time integration costs incurred in non-cash compensation, and reduced marketing and administrative payroll in 2019, offset by increases in sales payrollconnection the acquisition of Pistol Star, increased accounting and legal fees incurred in connection with financing transactions.transactions, employee bonuses, and costs associated with set up of the African subsidiary.

 


29

Research, development and engineering

 

  

Three months ended

September 30,

         
  

2019

  

2018

  

$ Change

  

% Change

 
                 

Research, development and engineering

 $300,131  $391,507  $(91,376

)

  -23

%

  

Three months ended

September 30,

         
  

2020

  

2019

  

$ Change

  

% Change

 
                 

Research, development and engineering

 $331,213  $300,132  $31,081   10

%

 

For the three months ended September 30, 2019,2020, research, development and engineering costs decreasedincreased approximately $91,000 (23%$31,000 (10%) as compared to the corresponding period in 2018, as a result of decreases in contracting services, non-cash compensation, and personnel and2020, directly related costs, offset by increased recruitingto the PistolStar R&D expenses.

  

Other income (expense)

 

 

Three months ended

September 30,

          

Three months ended

September 30,

        
 

2019

  

2018

  

$ Change

  

% Change

  

2020

  

2019

  

$ Change

  

% Change

 
                                

Interest income

  19   44   (25

)

  -57

%

 $1,106  $19  $1,087   5721

%

Interest expense

  (558,449

)

  -   (558,449

)

  n/a   (2,204,920

)

  (558,449

)

  (1,646,471

)

  295%

Total other income (expense)

 $(558,430

)

 $44  $(558,474

)

     $(2,203,814

)

 $(558,430

)

 $(1,645,384

)

  295

%

 

Interest expense for the 2019 period relatedand 2020 periods relates to the amortization of the debt discount and debt issuance costs incurred as a result of the convertible debt financings.  The 2020 total includes the write-off of unamortized discount and debt issuance costs related to the May 2020 and June 2020 notes which were paid in full during the three months ended September 30, 2020.

NINE MONTHS ENDED SEPTEMBER 30, 2020 AS COMPARED TO SEPTEMBER 30, 2019

Consolidated Results of Operations - Percent Trend

  

% of Total Revenues for the

Nine Months Ended

September 30,

 
  

2020

  

2019

 

Revenues

        

Services

  52

%

  41

%

License fees

  34

%

  14

%

Hardware

  13

%

  45

%

Total revenues

  100

%

  100

%

Costs and other expenses

        

Cost of services

  19

%

  12

%

Cost of license fees

  2

%

  65

%

Cost of hardware

  7

%

  26

%

Total costs and other expenses

  27

%

  103

%

Gross profit (loss)

  73

%

  -3

%

         

Operating expenses

        

Selling, general and administrative

  230

%

  193

%

Research, development and engineering

  56

%

  56

%

Total operating expenses

  286

%

  250

%

Operating loss

  -213

%

  -253

%

         

Other income (expense)

        

Total other income (expense)

  -251

%

  -39

%

Net loss

  -465

%

  -292

%

30

Revenues and costs of goods sold

  

Nine months ended

September 30,

         
  

2020

  

2019

  

$ Change

  

% Change

 

Revenues

                

Service

 $928,561  $710,975  $217,586   31

%

License

  605,366   241,780   363,586   150

%

Hardware

  239,025   779,965   (540,940

)

  -69

%

Total Revenue

 $1,772,952  $1,732,720  $40,232   2

%

                 

Cost of goods sold

                

Service

 $336,940  $214,933  $122,007   57

%

License

  29,486   1,119,147   (1,089,661

)

  -97

%

Hardware

  117,900   458,049   (340,149

)

  -74

%

Total COGS

 $484,326  $1,792,129  $(1,307,803

)

  -73

%

Revenues

For the nine months ended September 30, 2020 and 2019, service revenues included approximately $891,000 and $692,000, respectively, of recurring maintenance and support revenue, and approximately $38,000 and $19,000, respectively, of non-recurring custom services revenue.  Recurring service revenue increased 29% from 2019 which is largely due to the additional PistolStar service revenue customers in the three months ended September 30, 2020. Non-recurring custom services increased 100% for custom services due to increased new customer installations.

For the nine months ended September 30, 2020 and 2019, license revenue increased 150% while we increased the diversity and number of customers, including additional revenue from the PistolStar acquisition in the three months ended September 30, 2020.

For the nine months ended September 30, 2020 and 2019, hardware sales decreased by approximately $541,000 (69%), as a result of a decreased volume of lock orders and smaller new orders. 

Costs of goods sold

For the nine months ended September 30, 2020, cost of service increased approximately 57%, due to increase support required for existing custom support and PistolStar support in the three months ended September 30, 2020.

License costs for the nine months ended September 30, 2020 decreased approximately 97% and were directly associated with the amortization of the software rights in 2019 which were written off as of December 31, 2019.

Hardware costs for the nine months ended September 30, 2020 decreased approximately 74%. The decrease was associated with the reduced hardware sales and hardware mix.

Selling, general and administrative

  

Nine months ended

September 30,

        
  

2020

  

2019

  

$ Change

  

 

% Change

 
                 

Selling, general and administrative

 $4,083,568  $3,350,770  $732,798   22

%

Selling, general and administrative costs for the nine months ended September 30, 2020 increased 22% from the corresponding period in 2019. The increase included expenses associated with new marketing personnel and web-site integration of PistolStar, additional costs associated with the PistolStar office staff and expenses, one-time integration costs incurred in connection the acquisition of Pistol Star, increased accounting and legal fees incurred in connection with financing transactions, and costs associated with set up of the African subsidiary. These amounts were offset by a decrease in non-cash compensation.

31

Research, development and engineering

  

Nine months ended

September 30,

         
  

2020

  

2019

  

$ Change

  

% Change

 
                 

Research, development and engineering

 $986,675  $975,466  $11,209   1

%

For the nine months ended September 30, 2020, research, development and engineering costs increased approximately $11,000 (1%) as compared to the corresponding period in 2019, as a result of an increase in recruiting expenses and the addition of PistolStar expenses which amounts were offset by a decrease in contracting services and non-cash compensation.

Other income (expense)

  

Nine months ended

September 30,

         
  

2020

  

2019

  

$ Change

  

% Change

 
                 

Interest income

  26,908   143   26,765   18717

%

Government grant

  340,819   -   340,819   n/a 

Interest expense

  (4,323,577

)

  (673,316

)

  (3,650,261

)

  542

%

Loss on extinguishment of debt

  (499,076

)

  -   (499,076

)

  n/a 

Total other income (expense)

 $(4,454,926

)

 $(673,173

)

 $(3,781,753

)

  562

%

Other income (expense) for the 2020 period related to the interest expense, which included the amortization of a beneficial conversion feature, and amortization of debt discounts and debt issuance costs relating to the convertible notes of approximately $3,582,000, a loss on the extinguishment of a convertible debt financing in an approximate amount of $500,000, partially offset by amounts received under the Payment Protection Program of approximately $341,000 and interest income of approximately $27,000, mostly relating to the maturity of the investment.

 

The 2019 total includes the write-off of unamortized discount and debt issuance costs related to the April 2019 and June 2019 notes repaid prior to maturity.

 

NINE MONTHS ENDED SEPTEMBER 30, 2019 AS COMPARED TO SEPTEMBER 30, 2018

Consolidated Results of Operations - Percent Trend

  

% of Total Revenues for the

Nine Months Ended

September 30,

 
  

2019

  

2018

 

Revenues

        

Services

  41

%

  33

%

License fees

  14

%

  20

%

Hardware

  45

%

  47

%

Total revenues

  100

%

  100

%

Costs and other expenses

        

Cost of services

  12

%

  16

%

Cost of license fees

  65

%

  99

%

Cost of hardware

  26

%

  20

%

Total costs and other expenses

  103

%

  135

%

Gross Profit

  -3

%

  -35

%

         

Operating expenses

        

Selling, general and administrative

  193

%

  154

%

Research, development and engineering

  56

%

  46

%

Total operating expenses

  250

%

  200

%

Operating loss

  -253

%

  -235

%

         

Other income (expense)

        

Total other income (expense)

  -39

%

  -

%

Net loss

  -292

%

  -235

%

Revenues and costs of goods sold

  

Nine months ended

September 30,

         
  

2019

  

2018

  

$ Change

  

% Change

 

Revenues

                

Service

 $710,975  $777,309  $(66,334

)

  -9

%

License

  241,780   467,621   (225,841

)

  -48

%

Hardware

  779,965   1,084,416   (304,451

)

  -28

%

Total Revenue

 $1,732,720  $2,329,346  $(596,626

)

  -26

%

                 

Cost of goods sold

                

Service

 $214,933  $373,538  $(158,605

)

  -42

%

License

  1,119,147   2,297,390   (1,178,243

)

  -51

%

Hardware

  458,049   478,652   (20,603

)

  -4

%

Total COGS

 $1,792,129  $3,149,580  $(1,357,451

)

  -43

%


Revenues

For the nine months ended September 30, 2019 and 2018, service revenues included approximately $692,000 and $661,000, respectively, of recurring maintenance and support revenue, and approximately $19,000 and $116,000, respectively, of non-recurring custom services revenue.  Recurring service revenue increased 5% from 2018 as we continued to bundle maintenance agreements to our expanding customer license base, and renewed existing maintenance agreements with our legacy customers. Non-recurring custom services decreased 84% for custom services due to fewer customized software requests.

For the nine months ended September 30, 2019 and 2018, license revenue decreased 48% due to less large orders, while we increased the diversity and number of customers by executing additional smaller orders.

For the nine months ended September 30, 2019 and 2018, hardware sales decreased by approximately $304,000 (428%), as a result of a decreased volume of lock orders. 

Costs of goods sold

For the nine months ended September 30, 2019, cost of service decreased approximately 42%, due to reduced support required for existing custom services revenue.

License costs for the nine months ended September 30, 2019 decreased approximately 51% and were directly associated with the amortization of the software rights, in addition to lower revenue.

Hardware costs for the nine months ended September 30, 2019 decreased approximately 4%. The decrease was associated with the reduced hardware sales and hardware mix.

Selling, general and administrative

  

Nine months ended

September 30,

         
  

2019

  

2018

  

$ Change

  

% Change

 
                 

Selling, general and administrative

 $3,350,770  $3,587,308  $(236,538

)

  -7

%

Selling, general and administrative costs for the nine months ended September 30, 2019 decreased 7% from the corresponding period in 2018. The net decreases included decreases in, legal fees, non-cash compensation, and reduced marketing and administrative payroll in 2019, offset by increased sales payroll, and sales professional services.

Research, development and engineering

  

Nine months ended

September 30,

         
  

2019

  

2018

  

$ Change

  

% Change

 
                 

Research, development and engineering

 $975,466  $1,081,294  $(105,828

)

  -10

%

For the nine months ended September 30, 2019, research, development and engineering costs decreased approximately $106,000 (10%) as compared to the corresponding period in 2018, as a result of decreased contracting services, non-cash compensation, and personnel and related costs, offset by increased recruiting expenses.

Other income (expense)

  

Nine months ended

September 30,

         
  

2019

  

2018

  

$ Change

  

% Change

 
                 

Interest income

  143   64   79   123

%

Interest expense

  (673,316

)

  -   (673,316

)

  n/a 

Total other income (expense)

 $(673,173

)

 $64  $(673,237

)

    

Interest expense for the 2019 period related to the amortization of the debt discount and debt issuance costs incurred as a result of the convertible debt financings.

The total includes the write-off of unamortized discount and debt issuance costs related to the April 2019 and June 2019 notes repaid prior to maturity.


 

LIQUIDITY AND CAPITAL RESOURCES

 

Cash Flows

 

Net cash used for operations during the nine months ended September 30, 20192020 was approximately $1,879,000.$3,686,000. The cash used in operating activities was primarily attributable to the following items:

 

Net positive cash flows related to adjustments for non-cash expenses for depreciation, amortization, share-based compensation, and issuance of common stock to our non-employee directors of approximately $2,410,000 and decrease in accounts receivable of approximately $801,000.$5,772,000.

 

 

Net negative cash flows related to accounts receivable, prepayments, accounts payable, accruals, lease liabilities, and contract costsdeferred revenue of approximately $153,000$1,224,000 and our net loss for the nine months.

 

Approximately $543,000$2,203,000 was used for investing activities during the nine months ended September 30, 20192020 related primarily to the acquisition of PistolStar, a note receivable of $295,000 and $3,000 related to the purchasenet proceeds and purchases of a non-marketable bond investment for approximately $513,000 and capital expenditures of $29,000.investments.

 

Approximately $2,177,000$24,206,000 was provided by financing activities during the nine months ended September 30, 2019 from2020 consisting of the issuance of shares in our underwritten offering, exercise of warrants, and repayment of debt, and warrants issuance, less fees. 

 

At September 30, 2019,2020, we had net working capital of approximately $459,000$18,370,000 as compared to negative net working capital of approximately $3,000,000 at December 31, 2018.2019. 

 

Liquidity and Capital Resources

 

Since our inception, our capital needs have been principally met through proceeds from the sale of equity and debt securities.  We expect capital expenditures to be less than $100,000 during the next twelve months.  

 

The following sets forth our primary sources of capital during the previous two years:

32

 

We entered into an accounts receivable factoring arrangement with a financial institution (the “Factor”) which has since been extended through October 31, 2020. Pursuant to the terms of the arrangement, from time to time, we sell to the Factor a minimum of $150,000 of certain of our accounts receivable balances per quarter on a non-recourse basis for credit approved accounts. The Factor remits 35% of the foreign and 75% of the domestic accounts receivable balance to us (the “Advance Amount”), with the remaining balance, less fees, forwarded to us once the Factor collects the full accounts receivable balance from the customer. In addition, from time to time, we receive over advances from the Factor. Factoring fees range from 2.75% to 15% of the face value of the invoice factored, and is determined by the number of days required for collection of the invoice. We expect to continue to use this factoring arrangement periodically to assist with our general working capital requirements due to contractual requirements.   

 

On September 22, 2017, we issued to Wong Kwok Fong (Kelvin), a director, executive officer and principal stockholder of the Company, 427,778 shares of common stock and warrants to purchase 138,889 shares of common stock for an aggregate purchase price of $1,540,000, or $3.60 per share. The purchase consisted of a cash payment of $1,000,000 and the conversion of accrued dividends payable on the Company’s Series A-1 Convertible Preferred Stock of $540,000.

On August 24, 2018, we completed a public offering of units consisting of 1,380,000 shares of common stock and warrants to purchase 1,035,000 shares of common stock for an aggregate gross proceed of $2,070,000, or $1.50 per unit. During the first quarter of 2020, 972,000 warrants were exercised resulting in proceeds of approximately $1,450,000.

 

On April 4, 2019, we issued a $550,000 secured convertible debenture to an institutional investor with a maturity date of November 15, 2019 which was convertible into common stock at a conversion price of $1.50 per share. The debenture was redeemable at any time by payment of a premium to the principal balance starting at 5% and increasing to 20%.  The debenture was issued at a 7% original issue discount.  On July 10, 2019, this debenture was redeemed and repaid in full in connection with the financing described below.

 

On June 14, 2019, we issued a $157,000 principal amount convertible note to an institutional investor with a maturity date of November 14, 2019 which was convertible into common stock at a conversion price of $1.50 per share. The note was redeemable at any time by payment of a premium to the principal balance starting at 10% and increasing to 30%.  On July 10, 2019, this note was redeemed and repaid in full in connection with the financing described below.

 

On July 10, 2019, we issued a $3,060,000 principal amount senior secured convertible note (the “Note”“Original Note”) to an institutional investor. At closing, $2,550,000 was funded. The principal amount due of the Note is due and payable as follows: $918,000 is due 180 days after funding, $1,071,000 is due 270 days after funding, and the remaining balance is due 12 months after the date of funding. The Note iswas secured by a lien on substantially all of our assets and properties and iswas convertible into shares of our common stock at a fixed conversion price of $1.50 per share. Pursuant to amendments in the first and second quarter of 2020, we amended the Original Note to increase the principal amount to $3,789,000 as a result of interest and penalties, accelerated the maturity date to June 13, 2020, and reduced the conversion price to $0.65 per share (the “Amended Note”). The full balance of the Amended Note has been converted into common stock.

 On January 13, 2020, we issued a $157,000 principal amount convertible note to an institutional investor with a maturity date of June 13, 2020 which was convertible into common stock at a conversion price of $1.50 per share. The note was redeemable at any time by payment of a premium to the principal balance starting at 10% and increasing to 30%. This note was paid in full on June 12, 2020 by payment of $211,984.

On February 13, 2020, we issued a $126,000 principal amount convertible note to an institutional investor with a maturity date of July 13, 2020 which was convertible into common stock at a conversion price of $1.15 per share. The note was redeemable at any time by payment of a premium to the principal balance starting at 10% and increasing to 30%. This note was paid in full on July 10, 2020 by payment of $170,442.

On April 20, 2020, we entered into a Paycheck Protection Program Term Note (the “SVB Note”) with Silicon Valley Bank (“SVB”) pursuant to the Paycheck Protection Program (the “Program”) of the recently enacted Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) administered by the U.S. Small Business Administration. We received total proceeds of approximately $341,000 which was used in accordance with the requirements of the CARES Act. We will apply to SVB for forgiveness of amounts due on the SVB Note to the extent they are used for eligible payroll costs, rent obligations, and covered utility payments incurred during the “covered period” following disbursement under the SVB Note. Until the six-month anniversary of the date of the SVB Note (the “Deferral Expiration Date”), neither principal nor interest is due and payable. On the Deferral Expiration Date, the outstanding principal of the SVB Note that is not forgiven will convert to an amortizing term loan at an interest rate of 1% per annum requiring equal monthly payments of principal and interest through November 20, 2022. We expect that the full amount of the SVB Note will be forgiven.

On May 6, 2020, we issued a $2,415,000 principal amount senior secured convertible note. The principal amount was due and payable in five equal monthly installments of $268,333 beginning seven months after the funding date with the remaining balance due twelve months after the date of funding. Following the completion of the underwritten offering consummated in July 2020 discussed below, all outstanding amounts relating this note were paid in full.

On June 29, 2020, we issued a $1,811,250 principal amount senior secured convertible note. The principal amount was due and payable in nine equal monthly installments of $201,250 beginning four months after the funding date. Following the completion of the underwritten offering consummated in July 2020 discussed below, all outstanding amounts relating this note were paid in full.

On July 23, 2020, we completed an underwritten public offering of shares of common stock and warrants resulting in net proceeds of approximately $22.7 million, inclusive of the over-allotment and after deducting underwriting discounts and commissions and estimated offering expenses. We used approximately $4.2 million of the net proceeds to repay all outstanding amounts due under outstanding convertible promissory notes at that time.


33

 

Liquidity outlook

 

At September 30, 2019,2020, our total cash and cash equivalents were approximately $78,000,$18.4 million, as compared to approximately $324,000$79,000 at December 31, 2018.2019.

 

As discussed above, we have historically financed our operations through access to the capital markets by issuing secured and convertible debt securities, convertible preferred stock, common stock, and through factoring receivables. Excluding repayment of debt, wereceivables, and more recently via a public offering. We estimate that we currently require approximately $537,000$680,000 per month to conduct our operations, a monthly amount that we have been unable to consistently achieve through revenue generation. We expect additional cash requirements for the expansion of business in Africa, however, we will delay any increases in expenses until revenue will cover the added expenses. During the first nine months of 2019,2020, we generated approximately $1,732,000$1,773,000 of revenue, which is below our average monthly requirements.

 

If we are unable to continue to generate sufficient revenue to meet our goals, we will need to obtain additional third-party financing to (i) conduct the sales, marketing and technical support necessary to execute our plan to substantially grow operations, increase revenue and serve a significant customer base; and (ii) provide working capital. We may, therefore, need to obtain additional financing through the issuance of debt or equity securities. 

 

Due to several factors, including our history of losses and limited revenue, our independent auditors have included an explanatory paragraph in their opinion related to our annual financial statements as to the substantial doubt about our ability to continue as a going concern. Our long-term viability and growth will depend upon the successful commercialization of our technologies and our ability to obtain adequate financing. To the extent that we require such additional financing, no assurance can be given that any form of additional financing will be available on terms acceptable to us, that adequate financing will be obtained to meet our needs, or that such financing would not be dilutive to existing stockholders. If available financing is insufficient or unavailable or we fail to continue to generate sufficient revenue, we may be required to reduce operating expenses, delay the expansion of operations, be unable to pursue merger or acquisition candidates, or in the extreme case, not continue as a going concern.

 

34

 

ITEM 4.

CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of September 30, 2019.2020. Based on the evaluation of our disclosure controls and procedures as of September 30, 2019,2020, our CEO and CFO concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level. 

 

Changes in Internal Control Over Financial Reporting

 

No change in our internal control over financial reporting occurred during the fiscal quarter ended September 30, 2019,2020, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

PART II — OTHER INFORMATION

ITEM 2UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

We issued a warrant to a former employee to purchase 25,000 shares of common stock exercisable at a price of $ 0.65 per share in consideration for a business referral. The warrant has a term of seven years and is immediately exercisable. The foregoing securities were issued in a private placement transaction to one accredited investor pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, without general solicitation or advertising of any kind and without payment of placement agent or brokerage fees to any person.

 

ITEM 6. EXHIBITS

 

The exhibits listed in the Exhibit Index immediately preceding such exhibits are filed as part of this Report.

 


35

 

EXHIBIT INDEX

 

Exhibit

No.

 

Description

1.1*

Form of Underwriting Agreement (incorporated by reference to Exhibit 1.1 to Amendment No. 1 to the Registration Statement on Form S-1/A, filed with the SEC on July 17, 2020).

 

 

4.1

Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.2 to Amendment No. 1 to the Registration Statement on Form S-1/A, filed with the SEC on July 17, 2020).

4.2

Form of Warrant (incorporated by reference to Exhibit 4.3 to Amendment No. 1 to the Registration Statement on Form S-1/A, filed with the SEC on July 17, 2020).

4.3

Form of Warrant Agency Agreement (incorporated by reference to Exhibit 4.4 to Amendment No. 2 to the Registration Statement on Form S-1/A, filed with the SEC on July 20, 2020).

 

10.1

 

Form of Securities Purchase Agreement$500,000 Promissory note, dated July 10, 2019 by and between the Registrant and Lind Global Macro Fund, LPJune 30, 2020 (incorporated by reference to Exhibit 10,110.1 to the quarterly reportCurrent Report on Form 10-Q,8-K, filed with the SEC on August 14, 2019)July 7, 2020).

 

 

 

10.2

 

Form of SecuritySecurities Purchase Agreement dated July 10, 2019June 29, 2020 by and between the RegistrantCompany and Lind Global Macro Fund, LP.LP (incorporated by reference to Exhibit 10,210.1 to the quarterlycurrent report on Form 10-Q,8-K, filed with the SEC on August 14, 2019)July 1, 2020)

 

 

 

10.3

Form of Collateral SharingRestricted Stock Award Agreement dated July 10, 2019 by and amongunder the Registrant, Lind Global Macro Fund, LP and Versant Funding LLCBIO-key International, Inc. Amended & Restated 2015 Equity Incentive Plan (incorporated by reference to Exhibit 10,310.1 to the quarterlycurrent report on Form 10-Q,8-K, filed with the SEC on August 14, 2019).28, 2020)

 

10.4

Form of $3,060,00 Senior Secured Convertible Promissory Note dated July 10, 2019 (incorporated by reference to Exhibit 10,4 to the quarterly report on Form 10-Q, filed with the SEC on August 14, 2019).

10.5

Form of Common Stock Purchase Warrant dated July 10, 2019 (incorporated by reference to Exhibit 10,5 to the quarterly report on Form 10-Q, filed with the SEC on August 14, 2019).

31.1

Certificate of CEO of Registrant required under Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended

 

 

31.2

Certificate of CFO of Registrant required under Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended

 

 

32.1

Certificate of CEO of Registrant required under 18 U.S.C. Section 1350

 

 

32.2

Certificate of CFO of Registrant required under 18 U.S.C. Section 1350

 

 

101.INS

XBRL Instance

 

 

101.SCH

XBRL Taxonomy Extension Schema

 

 

101.CAL

XBRL Taxonomy Extension Calculation

 

 

101.DEF

XBRL Taxonomy Extension Definition

 

 

101.LAB

XBRL Taxonomy Extension Labels

 

 

101.PRE

XBRL Taxonomy Extension Presentation

 


36

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  

BIO-key International, Inc.

  

  

Dated: November 14, 201916, 2020

/s/ Michael W. DePasquale

  

Michael W. DePasquale

  

Chief Executive Officer

  

(Principal Executive Officer)

  

  

Dated: November 14, 201916, 2020

/s/ Cecilia Welch

  

Cecilia Welch

Chief Financial Officer

  

(Principal Financial Officer)

 

31

37